{
  "metadata": {
    "timestamp": "2025-12-16T21:51:59.043415",
    "genes": [
      "FAM189A2",
      "OGFRL1",
      "MAP3K5",
      "ITPR2",
      "ETNPPL",
      "NRG3",
      "CD38",
      "FMN2",
      "LINC01088",
      "KCNN3",
      "DAAM2",
      "AC002429.2",
      "OBI1-AS1",
      "NTRK2",
      "SYTL4",
      "WDR49",
      "ADGRV1",
      "LIFR",
      "AQP4",
      "ID3",
      "OSBPL11",
      "DPP10",
      "SERPINI2",
      "TLR4",
      "NAA11",
      "MGAT4C",
      "AC026316.5",
      "EEPD1",
      "RASSF4",
      "AL392086.3",
      "SLC4A4",
      "EDNRB",
      "SLC39A11",
      "ATP1A2",
      "SLCO1C1",
      "AHCYL2",
      "SPON1",
      "SLC1A3",
      "GRAMD2B",
      "DTNA",
      "AC012405.1",
      "NKAIN3",
      "NTM",
      "SLC14A1",
      "DCLK2",
      "DCLK1",
      "ID4",
      "AC124854.1",
      "LINC01094",
      "PCDH9",
      "GABBR2",
      "PARD3B",
      "PDE8A",
      "LRIG1",
      "C5ORF64",
      "RNF19A",
      "SPARCL1",
      "AC093535.1",
      "FADS2",
      "PLEKHA5",
      "ASTN2",
      "ADAMTS9",
      "AC073941.1",
      "SLC24A4",
      "PAPPA",
      "AC068587.4",
      "FARP1",
      "SORL1",
      "ARHGAP26",
      "CADPS",
      "ST3GAL6",
      "ITPKB",
      "GABRB1",
      "FAM107A",
      "MIR99AHG",
      "ANK2",
      "AC107223.1",
      "PPP2R2B",
      "LPL",
      "AL589935.1",
      "MRVI1",
      "TNIK",
      "AL160272.1",
      "AC016766.1",
      "RANBP3L",
      "ARHGEF4",
      "ADCY2",
      "NPL",
      "KCNQ5",
      "AC079352.1",
      "LIX1",
      "APOE",
      "SLC25A48",
      "ADCYAP1R1",
      "AHCYL1",
      "RASL12",
      "GINS3",
      "PTPRG",
      "AL096709.1",
      "BMP2K",
      "MCF2L2",
      "RBMS3",
      "SLCO3A1",
      "AL445426.1",
      "CARMIL1",
      "CACNA2D3",
      "CDHR3",
      "NAV3",
      "UTRN",
      "NRP2",
      "DNAH7",
      "KIAA1671",
      "HPSE2",
      "COL4A5",
      "AC083864.5",
      "L3MBTL4",
      "AC092131.1",
      "PCSK6",
      "AC097450.1",
      "ANOS1",
      "SYNPO2",
      "LINC00836",
      "MAPK4",
      "AL365259.1",
      "WNK2",
      "LMO3",
      "SSBP2",
      "SLC1A4",
      "PPP2R5A",
      "LINC00299",
      "SLC15A2",
      "CNTN1",
      "FKBP5",
      "GREB1L",
      "LUZP2",
      "MAP7",
      "AC023095.1",
      "IGFBP7",
      "ALDH1A1",
      "GRAMD1C",
      "RHBDL3",
      "DAPK1",
      "LINC02058",
      "TENM4",
      "RTN1",
      "LINC01138",
      "GLUD1",
      "NEBL",
      "LINC01117",
      "AC092691.1",
      "TJP2",
      "PCDH9-AS2",
      "YAP1",
      "ABCC9",
      "LAMA1",
      "AL137024.1",
      "ERBB4",
      "ADRA1A",
      "MYBPC1",
      "NT5DC3",
      "AQP1",
      "NKAIN4",
      "ARAP2",
      "RHOB",
      "AQP4-AS1",
      "CDH20",
      "RGMA",
      "OSGIN2",
      "PRKG1",
      "MROH7",
      "PRRX1",
      "MAST4",
      "CHL1",
      "PAPLN",
      "OSBPL3",
      "RFX4",
      "CD44",
      "ATP13A4",
      "COL5A3",
      "ITGA6",
      "DOCK7",
      "CPE",
      "DPF3",
      "ZNF521",
      "DHRS3",
      "AC006148.1",
      "LMNTD1",
      "AC092924.2",
      "LHFPL6",
      "AC024145.1",
      "LIMCH1",
      "SRPX2",
      "AL590999.1",
      "ADCY8",
      "AC008957.2",
      "TTYH2",
      "GJA1",
      "SHROOM3",
      "USH1C",
      "AC007262.2"
    ],
    "context": "Astrocytoma",
    "provider": "perplexity",
    "model": "sonar-deep-research",
    "source": "scripts/run_deepsearch.py",
    "preset": "perplexity-sonar-schema-embedded",
    "template": null,
    "custom_prompt_used": false,
    "provider_override": null,
    "model_override": null,
    "reasoning_effort_override": null,
    "search_recency_override": null,
    "timeout_seconds": 180,
    "effective_provider": "perplexity",
    "effective_model": "sonar-deep-research",
    "project": "Astrocytoma_nmf",
    "query": "Cluster_0",
    "source_tag": null,
    "resolve_citations": true,
    "citation_flags": {
      "validate": true,
      "scrape": false,
      "pdf": true,
      "topic_validation": false
    }
  },
  "raw_response": {
    "markdown": "<think>\nThe user is asking me to perform a comprehensive literature analysis on a large gene list (approximately 180+ genes) in the context of astrocytoma. They want me to:\n\n1. Search literature for functional roles of each gene\n2. Identify gene clusters acting together in pathways\n3. Treat each cluster as a potential gene program\n4. Interpret in light of normal physiology and disease alterations\n5. Provide both a narrative report AND JSON output\n\nThe biological context is **astrocytoma** and the cell type is **astrocytes**.\n\nLooking at my search results, I have access to several relevant papers:\n- Papers on astrocyte biology, astrocytoma, glioblastoma\n- Papers on astrocyte metabolism, gene expression\n- Papers on BBB function and astrocytes\n- Papers on neuroinflammation and astrocyte reactivity\n- Papers on TBI and astrocyte activation\n- Papers on various molecular pathways in gliomas\n\nLet me think through what major gene programs I can identify from this gene list in the context of astrocytoma:\n\n1. **Ion homeostasis and channels** - ATP1A2, KCNN3, KCNQ5, SLC4A4, AQP4, ITPR2, CACNA2D3, ABCC9\n2. **Glutamate handling and neurotransmitter transport** - SLC1A3, SLC1A4, SLC15A2, SLC24A4, SLC14A1, SLC39A11, SLC25A48\n3. **Cell adhesion and ECM interactions** - ITGA6, CADPS, COL4A5, ADAMTS9, SPARCL1, LAMA1, PCDH9\n4. **Cytoskeletal dynamics** - DAAM2, FMN2, SHROOM3, LIMCH1, ASTN2, MAP7, NEBL, DTNA\n\n\n5. **Growth factor signaling and receptor pathways** - NTRK2, ERBB4, NRG3, ADCY2, ADCY8, PRKG1, ADRA1A\n6. **Lipid and cholesterol metabolism** - APOE, LPL, FADS2, OSBPL11, OSBPL3, AHCYL1, AHCYL2\n7. **Reactive astrocyte activation and immune response** - CD44, TLR4, CD38, ID3, ID4, YAP1\n8. **Proliferation and stemness programs** - ID3, ID4 and related factors including RFX4, ZNF521\n9. **Cell-cell communication through gap junctions** - GJA1, LRIG1, C5ORF64\n10. **Protein processing and turnover** - PCSK6, HPSE2, RNF19A\n11. **Gene expression control** - YAP1, RFX4, ZNF521, RBMS3, SSBP2\n12. **Metabolic enzyme activity** - GLUD1, DHRS3, NT5DC3, NPL, BMP2K\n\nNow I need to develop a comprehensive framework that weaves these functional modules into a coherent narrative about astrocytoma biology. The report should integrate findings across these pathways while maintaining analytical depth and proper documentation throughout.\n</think>\n\n# Comprehensive Gene Program Analysis of Astrocyte Molecular Signatures in Astrocytoma\n\nThis report presents a systematic functional analysis of 180+ genes with particular relevance to astrocyte biology and astrocytoma pathogenesis. Through integration of current literature on astrocyte physiology, glioma biology, and molecular pathway analysis, we identify eleven distinct gene programs that collectively define critical cellular processes altered in astrocytoma. These programs span ion homeostasis, glutamate metabolism, cell-cell communication, cytoskeletal regulation, signal transduction, lipid metabolism, and reactive transformation. Multiple genes from the input list converge on pathways essential for both normal astrocyte functions and malignant transformation, with particular emphasis on programs governing metabolic flexibility, barrier function maintenance, and neuroinflammatory responses. Integration of these programs provides a comprehensive molecular framework for understanding astrocytoma biology at the cell program level.\n\n## Astrocyte Identity and Fundamental Gene Expression Patterns\n\nAstrocytes represent the most abundant glial cell type in the central nervous system and serve multifaceted roles extending far beyond their historical characterization as supportive cells[1][43]. The molecular identity of astrocytes is established through expression of canonical markers including glial fibrillary acidic protein (GFAP), aquaporin-4 (AQP4), and aldehyde dehydrogenase 1 family member A1 (ALDH1A1), with these markers reflecting active metabolic and structural functions essential to astrocyte physiology[9][43]. More recent single-cell transcriptomic and spatial profiling approaches have revealed substantial heterogeneity within the astrocyte population, with distinct transcriptional states associated with different anatomical locations, developmental stages, and pathological conditions[21][67]. The gene list provided demonstrates enriched representation of genes characteristically expressed in astrocytes or rapidly dysregulated during astrocyte activation and pathological transformation, suggesting that these genes collectively encode the molecular machinery underlying both homeostatic astrocyte functions and disease-associated cellular states. Understanding how multiple gene programs coordinate to maintain astrocyte identity while simultaneously enabling malignant transformation in astrocytoma requires systematic dissection of the functional roles these genes play in both physiological and pathological contexts.\n\n## Ion Homeostasis and Intracellular Calcium Regulation Programs\n\nAstrocytes maintain precise control over extracellular ion concentrations and intracellular calcium dynamics through coordinated action of ion channels, transporters, and regulatory proteins[9][40]. A prominent gene program within the provided list comprises aquaporin-4 (AQP4), ATP1A2, KCNN3, KCNQ5, and ITPR2, which collectively regulate water transport, sodium-potassium pump function, and calcium release. The sodium-potassium ATPase encoded by ATP1A2 represents a central node in this network, functioning not only as a primary ATP consumer but also as a regulator of intracellular sodium concentrations that drive multiple secondary transport processes[32][40]. Astrocytes express exceptionally high levels of ATP1A2 compared to other cell types, reflecting their energetic demands for maintaining the electrochemical gradients essential for glutamate uptake and the astrocyte-neuron lactate shuttle[9][32]. The significance of this program extends to its dysregulation in disease states; for instance, evidence suggests that alterations in astrocytic calcium handling through ITPR2 and related calcium-mobilizing systems contribute to both acute neuroinflammation and chronic neurodegeneration[22][40]. Aquaporin-4, which facilitates rapid water transport across astrocyte membranes particularly at perivascular endfeet, plays essential roles in regulating interstitial volume and maintaining the structural integrity of the blood-brain barrier[9][43]. In astrocytoma, disrupted ion homeostasis may facilitate tumor cell proliferation and invasion by enabling rapid cell volume changes necessary for migration through restrictive tissue environments.\n\nThe KCNN3 potassium channel and KCNQ5 voltage-gated potassium channel represent additional elements of this program, modulating membrane potential and calcium-dependent processes essential for astrocyte function[56][57]. The hyperpolarization-activated cyclic nucleotide-gated channel family and other ion channels work in concert with ATP1A2 and aquaporins to enable astrocytes to respond dynamically to neuronal activity while maintaining metabolic support and waste clearance[32]. SLC4A4, which encodes the sodium bicarbonate cotransporter NBCe1, contributes to pH regulation and osmotic balance essential for astrocyte volume control[40]. The interconnection between ion homeostasis and astrocyte reactivity is particularly evident in studies of traumatic brain injury, where persistent alterations in astrocytic ion handling associate with chronic neuroinflammatory states that may facilitate glioma development in the context of accumulated genetic alterations[21]. The program collectively enables rapid astrocyte responses to changing environmental conditions while maintaining the precise physicochemical environment required for neuronal function.\n\n## Glutamate Metabolism and Excitatory Neurotransmitter Handling\n\nGlutamate metabolism represents one of the most critical astrocyte functions, with astrocytes serving as the primary site of glutamate-glutamine cycling essential for both neuronal survival and synaptic plasticity[9][32]. The gene program centered on glutamate transport and metabolism includes SLC1A3 (EAAT1/GLT-1), SLC1A4 (ASCT2), GLUD1 (glutamate dehydrogenase), and potentially ITPKB (inositol 1,4,5-trisphosphate 3-kinase B), which coordinately regulate glutamate uptake, metabolism, and recycling[9][32]. SLC1A3 encodes the primary high-affinity glutamate transporter in astrocytes, responsible for the majority of synaptic glutamate clearance, and functions as a critical regulator of excitatory neurotransmission and excitotoxicity prevention[9][10]. The coupling between glutamate transport and energy metabolism is intimate; glutamate uptake through SLC1A3 drives sodium influx that activates ATP1A2, which in turn stimulates glycolysis and lactate production via the astrocyte-neuron lactate shuttle hypothesis[32][40]. This tight linkage between the glutamate transport program and the ion homeostasis program illustrates the hierarchical organization of astrocyte physiology, wherein multiple gene programs work synergistically to maintain neuronal health. The glutamate-glutamine cycle itself depends critically on glutamine synthetase, which catalyzes the ATP-dependent conversion of glutamate to glutamine; recent evidence reveals that this enzyme is regulated by YAP through Hippo pathway signaling, and that elevated ammonia levels can disrupt this regulation, suggesting potential involvement of YAP1 from the provided gene list[22]. SLC15A2, which encodes a peptide transporter that also handles certain amino acids, may contribute additional capacity for glutamate-related metabolism. In astrocytoma, dysregulation of glutamate handling programs is particularly significant, as aberrant glutamate signaling through tumor astrocytes can drive neuronal excitotoxicity while simultaneously promoting tumor cell invasiveness through paracrine effects on the tumor microenvironment[28].\n\n## Aquaporin-Water-Ion-Metabolism Coupled Program\n\nAstrocytic aquaporin-4 (AQP4), encoded by AQP4 in the provided list, merits special attention as it operates at the intersection of multiple distinct programs including ion homeostasis, cell volume regulation, and immune function[3][9]. AQP4 exists in two major isoforms produced through alternative splicing, M1 and M23, with AQP4-M23 forming orthogonal arrays of particles (OAPs) at astrocytic endfeet where it facilitates rapid water transport and serves as a target for autoimmune attack in aquaporin-4-seronegative neuromyelitis optica spectrum disorder[3]. The coupling between AQP4 and ATP1A2 is particularly intimate at perivascular endfeet, where astrocytes wrap around capillaries and regulate water movement in response to neuronal activity and changes in blood osmolarity[9][40]. AQP1, also present in the provided gene list, may complement astrocytic AQP4 function in certain contexts. The regulation of AQP4 expression and localization involves complex interactions with the extracellular matrix and structural proteins like dystrophin (DTNA in the list), linking this program to the cytoskeletal organization program. In reactive astrocytes associated with aging, neuroinflammation, or neoplastic transformation, alterations in AQP4 expression and localization contribute to blood-brain barrier dysfunction and altered microenvironmental osmolarity, potentially facilitating tumor cell proliferation and invasiveness[9][21].\n\n## Signal Transduction and Growth Factor Responsiveness Programs\n\nThe provided gene list contains multiple components of growth factor signaling cascades essential for astrocyte development, maintenance, and pathological activation. NTRK2 (tropomyosin receptor kinase B, also called TrkB), encoded by one of the central genes in the list, plays a particularly important role in astrocyte survival and stress responses through its ligand brain-derived neurotrophic factor (BDNF)[21][26]. NTRK2 signaling activates multiple downstream pathways including the mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K)-AKT pathway, both of which promote cell survival and metabolic adaptation[21][26]. The neuregulin-3 (NRG3) in the provided list represents another component of growth factor signaling, functioning through ErbB receptor family members including ERBB4 to promote neuronal and glial development and survival[13][26]. The coupling between NTRK2 and NRG3 signaling may create regulatory redundancy or context-dependent signaling integration, enabling astrocytes to respond to diverse developmental and injury-related signals. Adenylyl cyclase genes including ADCY2 and ADCY8 produce cAMP, a critical second messenger that mediates responses to numerous extracellular signals and regulates both astrocyte basal metabolism and inflammatory responses[14]. The downstream effector PRKG1 (protein kinase G1), activated by cGMP in response to nitric oxide signaling, represents an additional convergence point for multiple signaling cascades. In astrocytoma, dysregulation of growth factor signaling through NTRK2, ERBB4, and related receptors can drive tumor cell proliferation and survival, while sustained activation of cAMP and related pathways may support metabolic adaptation to the hypoxic tumor microenvironment. Notably, recent evidence highlights that certain astrocytoma subtypes, particularly those driven by NTRK fusion genes, show exceptional responsiveness to NTRK inhibitors, underscoring the pathogenic importance of this signaling axis in specific disease contexts[26].\n\n## Cytoskeletal Organization and Cell Morphodynamics Programs\n\nAstrocytes possess highly elaborate branched morphologies with dozens of processes extending to contact neurons, vasculature, and other glial cells, a morphological complexity enabled by sophisticated cytoskeletal regulation[40][57]. The gene program governing cytoskeletal dynamics includes genes encoding formin family proteins (FMN2, DAAM2), Rho GTPase regulators (ARHGAP26, ARHGEF4, MCF2L2), and structural proteins (ASTN2, NEBL, MAP7)[40][56][57]. Formins like FMN2 and DAAM2 are actin polymerization nucleators that promote formation of linear actin filaments critical for filopodia extension and retraction, processes essential for astrocyte process dynamics and synaptic contact formation[56]. The Plexin-B1 guidance receptor, while not directly in the provided list, represents a key regulator of astrocyte process dynamics through its effects on Rac1 activation mediated by Rho GTPase effectors, and this pathway can be inferred to be modulated by genes like ARHGAP26 and ARHGEF4[57]. LIMCH1 (LIM and calponin homology domains 1), a member of the calponin family of actin-binding proteins, likely contributes to process stabilization and contractility. The dystrophin-associated protein complex, represented in the list by DTNA (dystrophin-associated protein A), anchors the cytoskeleton to the extracellular matrix and membrane proteins, providing structural support essential for astrocyte endfeet stability at the blood-brain barrier[9][40]. SHROOM3, which encodes a scaffolding protein critical for actin bundle assembly and cell shape regulation, represents another key component of this program. Recent studies demonstrate that loss of Plexin-B1 in astrocytes results in reduced process motility, abnormal clustering, and altered alignment of astrocytes, with accompanying changes in reactive astrocyte markers[57]. These findings suggest that the cytoskeletal program is intimately connected to astrocyte reactivity and potentially to the balance between homeostatic versus neurotoxic astrocyte states in disease contexts.\n\n## Cell Adhesion and Extracellular Matrix Interaction Programs\n\nAstrocytes are embedded within a complex extracellular matrix (ECM) and form extensive cell-cell contacts through adhesion molecules essential for maintaining tissue architecture and facilitating intercellular communication[40][43]. The gene program encompassing cell adhesion and ECM interactions includes genes encoding cadherins and related adhesion molecules (PCDH9, CDH20, possibly CHL1), integrins and their ligands (ITGA6), and ECM proteins (ADAMTS9, SPARCL1, LAMA1, COL4A5)[6][40][43]. Protocadherin-9 (PCDH9) represents a member of the large clustered protocadherin family, with roles in cell-cell recognition and adhesion that influence astrocyte morphology and positioning[40]. ADAMTS9 (a disintegrin and metalloproteinase with thrombospondin motifs 9) encodes an ECM protease that remodels the astrocyte microenvironment through proteolytic processing of ECM proteins, potentially affecting both astrocyte migration and intercellular signaling[6]. The expression of ECM proteins including SPARCL1 (SPARC-like protein 1), LAMA1 (laminin alpha-1), and COL4A5 (collagen type IV alpha-5 chain) by astrocytes contributes to basement membrane formation and ECM network integrity at the blood-brain barrier[6][40][43]. The integrin ITGA6 mediates interactions between astrocytes and ECM ligands including laminins and other adhesion proteins, transducing bidirectional signals that influence astrocyte differentiation, survival, and functional state. Recent spatial transcriptomic analyses reveal that the ECM composition and expression patterns are substantially altered in glioblastoma versus lower-grade astrocytoma and normal brain, suggesting that dysregulation of ECM interaction programs contributes to gliomagenesis[6]. The metalloproteinase inhibitor TIMP1, while not in the provided list, would be expected to counterbalance the ECM-remodeling functions of ADAMTS9 and related proteases, making its dysregulation in astrocytoma particularly consequential for controlling ECM architecture and stiffness. CDH20, a cadherin family member, likely contributes additional adhesive specificity in astrocyte networks.\n\n## Gap Junction Communication and Intercellular Coupling Programs\n\nAstrocytes form extensive electrical and metabolic coupling networks through gap junction channels, enabling synchronized responses to neuronal activity and coordinated regulation of the local microenvironment[40][62]. The gene program governing gap junctional coupling is centered on GJA1 (connexin 43), the primary connexin in astrocytes, which oligomerizes to form gap junction channels permeable to ions and small molecules including ATP, glucose, and metabolic intermediates[40][62]. GJA1 expression is dynamically regulated in response to astrocyte activation, with both increases and decreases observed depending on the specific inflammatory context and stage of reactivity[40][62]. The regulation of GJA1 occurs through multiple mechanisms including post-translational modification by kinases like AKT, and transcriptional control through signaling cascades initiated by growth factors and inflammatory cytokines[40][62]. Additional proteins regulating gap junction stability and function, while not directly in the provided list, include proteins like zonula occludens proteins (ZO-1), which scaffold gap junctions and coordinate with tight junction proteins. LRIG1 (leucine-rich repeats and immunoglobulin-like domains 1), a membrane protein with roles in EGFR regulation and potentially affecting cell-cell interactions, may provide regulatory input to gap junction function. The connexin 43 encoded by GJA1 serves as a hub for direct interaction with numerous signaling proteins and contributes to both electrical coupling and signaling functions in astrocyte networks[62]. In the context of astrocytoma, astrocyte gap junctions are frequently dysregulated or lost as transformation proceeds, which disrupts coordinated astrocyte responses and may contribute to spatial heterogeneity in the tumor microenvironment[6][40]. However, in early-stage astrocytoma and diffuse infiltrating tumors, residual gap junctional coupling between tumor astrocytes and surrounding normal astrocytes may enable paracrine signaling that promotes tumor progression and limits antitumor immune responses.\n\n## Lipid Metabolism and Apolipoprotein-E Signaling Program\n\nAstrocytes play central roles in lipid homeostasis and delivery to neurons, with astrocyte-derived apolipoprotein E (APOE) serving as the predominant cholesterol carrier in the central nervous system and a critical regulator of Alzheimer disease risk and neuroinflammation[14][16][32]. The gene program encompassing lipid metabolism includes APOE, lipoprotein lipase (LPL), fatty acid desaturase 2 (FADS2), oxysterol-binding proteins (OSBPL11, OSBPL3), and Akt/AMPK-related metabolic regulators. APOE is synthesized primarily by astrocytes and circulates in cerebrospinal fluid and parenchymal interstitium, being taken up by neurons through receptor-mediated endocytosis dependent on ApoE receptors including LDL receptor-related protein 1[14]. The three isoforms of APOE (ε2, ε3, ε4) differ in a critical domain structure that affects lipid binding capacity and receptor interactions, with the APOE ε4 isoform being a major genetic risk factor for Alzheimer disease and also associating with altered astrocyte reactivity and neuroinflammatory responses[14]. Recent evidence demonstrates that APOE ε4 potentiates astrocyte-mediated neuroinflammation and tau pathology through mechanisms involving disrupted lipid metabolism and impaired lipid shuttling between astrocytes and neurons[14]. LPL, synthesized by astrocytes and other cell types, catalyzes hydrolysis of triglycerides in circulating lipoproteins, generating free fatty acids available for cellular uptake and utilization[16][32]. FADS2 encodes a fatty acid desaturase catalyzing synthesis of polyunsaturated fatty acids critical for membrane composition and signaling molecule production[16]. OSBPL11 and OSBPL3 (oxysterol-binding protein-like proteins) function as lipid sensors and regulators of intracellular cholesterol homeostasis, connecting lipid abundance to transcriptional control and metabolic adaptation[16][24]. The YAP1 program discussed below directly intersects with astrocytic lipid metabolism through its role in regulating SREBP1-mediated lipogenesis, providing mechanistic integration between metabolic flexibility and growth signaling[24]. In astrocytoma, dysregulated lipid metabolism contributes both to tumor cell survival through enhanced membrane biogenesis and to altered astrocyte-derived lipid support of the tumor microenvironment[16][32].\n\n## Reactive Astrocyte and Neuroinflammation Marker Program\n\nReactive astrocytes display characteristic morphological, molecular, and functional changes in response to central nervous system injury, infection, or pathology, and these reactive states represent a heterogeneous spectrum rather than a simple binary activated/inactive dichotomy[14][21][40]. The gene program governing astrocyte reactivity includes transcription factors (ID3, ID4, YAP1, RFX4), surface antigens (CD44, CD38), and pattern recognition receptors (TLR4). CD44, a receptor for hyaluronic acid and other ligands, is upregulated on reactive astrocytes and serves as both a marker and functional driver of reactive astrocyte phenotypes, facilitating interactions with immune cells and ECM components[14]. CD38, a NAD+-consuming enzyme and signaling molecule, is upregulated in reactive astrocytes and microglia in neuroinflammatory conditions including Alzheimer disease and may contribute to altered NAD+ metabolism and energy homeostasis in reactive astrocytes[8][14]. TLR4 (toll-like receptor 4), which recognizes bacterial lipopolysaccharide and damage-associated molecular patterns, is expressed on astrocytes and drives pro-inflammatory signaling through NF-κB when activated[7][14]. The inhibitor of DNA binding proteins ID3 and ID4 are upregulated in reactive astrocytes and function to promote astrocyte proliferation while simultaneously antagonizing terminal differentiation programs[14]. YAP1 (yes-associated protein 1), a critical transcriptional co-activator downstream of Hippo pathway signaling, plays multiple roles in astrocyte biology including promotion of reactive astrogliosis while simultaneously supporting neuroprotective functions through metabolic regulation[22][24][40]. The interaction between YAP and TEAD transcription factors drives expression of multiple pro-inflammatory genes while simultaneously promoting astrocyte metabolic adaptation and survival in response to stress[22][24]. RFX4 (regulatory factor X4), a transcription factor with roles in neuronal differentiation and potential astrocyte regulation, may contribute context-dependent modulation of astrocyte gene programs. The reactive astrocyte phenotype in astrocytoma includes features characteristic of both pro-inflammatory (A1-like) and metabolically supportive (A2-like) phenotypes, with different tumor regions displaying distinct astrocyte transcriptional states[21]. Evidence suggests that reactive astrocytes at the tumor margin adopt phenotypes that support rather than oppose tumor progression, through suppression of anti-tumor immunity and provision of metabolic support to infiltrating tumor cells[21][40].\n\n## Calcium Signaling and Synaptic Plasticity Regulatory Program\n\nBeyond its role in cellular volume regulation, intracellular calcium serves as a critical second messenger regulating astrocyte metabolic state, gene expression, and synaptic interactions[21][40][56]. The gene program governing calcium signaling includes ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), voltage-gated calcium channels (CACNA2D3 encodes an auxiliary subunit of L-type calcium channels), and calcium-dependent effectors including calcineurin and calmodulin-dependent kinases. ITPR2, which gates calcium release from the endoplasmic reticulum in response to inositol 1,4,5-trisphosphate (IP3) generated downstream of phospholipase C activation, represents a central node in calcium signaling that links growth factor and neurotransmitter receptor activation to changes in intracellular calcium[22][40]. Recent studies reveal that ITPR2-mediated calcium release and mitochondrial calcium uptake through the mitochondrial calcium uniporter promotes senescence in multiple cell types, and that alterations in mitochondrial calcium handling contribute to both acute and chronic neuroinflammatory states[22][35]. CACNA2D3, encoding the alpha-2/delta-3 auxiliary subunit of calcium channels, regulates calcium channel trafficking and function, with particular roles in neuron-astrocyte interactions at synapses[32]. The downstream calcium-responsive effectors, while not all directly in the list, include calcineurin and NFAT family transcription factors, which recent evidence implicates in linking astrocyte calcium dysregulation to aberrant inflammatory responses and compromised neurovascular coupling[40]. The coupling between calcium signaling and synaptic plasticity occurs through calcium-dependent modulation of astrocytic expression of synapse-modulating proteins and metabolite provision[19][32][40]. In astrocytoma, dysregulated calcium signaling may both promote tumor cell proliferation through sustained pro-survival signaling and simultaneously create a pro-inflammatory microenvironment that selects for tumor cells capable of thriving in high-activity conditions[21][40].\n\n## Transcriptional Regulation and Stem Cell Maintenance Programs\n\nThe genes encoding inhibitors of DNA binding (ID3, ID4) and multiple additional transcriptional regulators (YAP1, RFX4, ZNF521) form a gene program governing cell proliferation, differentiation, and stemness maintenance[14][24][28][52]. ID proteins function as dominant-negative inhibitors of basic helix-loop-helix transcription factors critical for differentiation, and their upregulation in reactive astrocytes and glioma stem cells promotes continued proliferation while antagonizing terminal differentiation[14][28][52]. YAP1, as discussed in multiple program sections above, serves as a master regulator of stem cell properties and metabolic flexibility through both canonical Hippo pathway-independent activities and integration with NOTCH and WNT signaling[22][24][28]. The transcription factor RFX4 plays roles in neuronal lineage specification and may serve analogous functions in regulating astrocyte differentiation state and plasticity. ZNF521 (zinc finger protein 521) has been implicated in stem and progenitor cell maintenance across multiple tissues. The recent discovery that glioblastoma progression involves activation of a neuronal progenitor state driven by the transcription factor INSM1, combined with maintenance of plasticity through ID and YAP signaling, suggests that astrocytoma may similarly involve deregulation of transcriptional programs normally governing stem and progenitor cell states[28]. This program directly enables the cellular plasticity characteristic of astrocytoma, wherein tumor cells can transition between differentiated astrocytic, oligodendroglial-progenitor-like, and neural-progenitor-like states depending on microenvironmental pressures and acquired mutations[28][52].\n\n## Amino Acid Transport and Metabolic Adaptation Program\n\nBeyond the glutamate handling program discussed earlier, astrocytes express multiple additional amino acid transporters enabling metabolic flexibility and nutritional support to neurons[9][10][32]. The broader amino acid transport program includes SLC1A3 and SLC1A4 (discussed above), as well as SLC15A2 (peptic transporter PEPT2), SLC24A4 (potassium-dependent sodium-calcium exchanger), SLC39A11 (zinc transporter), and SLC25A48 (mitochondrial transporter). These transporters collectively enable astrocytes to sense and respond to fluctuations in extracellular and intracellular amino acid availability, coordinate with neuronal demand for specific amino acids, and maintain appropriate intracellular metabolite pools for both protein synthesis and energy metabolism[9][10][32]. SLC14A1 (urea transporter), while traditionally associated with kidney physiology, has emerging roles in osmolyte transport relevant to astrocyte volume regulation. SLCO1C1 and SLCO3A1, members of the solute carrier organic anion transporter family, may facilitate transport of clinically relevant substrates including steroid hormones and metabolites, with potential roles in astrocyte responses to systemic endocrine signals. GLUD1 (glutamate dehydrogenase), which catalyzes bidirectional conversion between glutamate and α-ketoglutarate, serves as a critical hub linking amino acid metabolism to the tricarboxylic acid cycle and energy production[32][40]. The coupling between amino acid transport and metabolic state enables astrocytes to shift between different metabolic programs depending on energy demand, oxygen availability, and neuronal activity levels[32]. In astrocytoma, enhanced amino acid transport capacity likely contributes to the rapid proliferation and metabolic demands of tumor cells, with tumor-derived astrocytes potentially being particularly adept at nutrient scavenging and channeling resources to malignant progeny[28].\n\n## Cellular Senescence and Mitochondrial Quality Control Program\n\nAstrocytes in aging brain and in chronic neurodegenerative disease accumulate features of cellular senescence including altered mitochondrial function, persistent DNA damage responses, and production of pro-inflammatory senescence-associated secretory phenotype (SASP) factors[21][35][64]. The gene program governing mitochondrial quality control includes components of autophagy (BECN1, ATG machinery), mitophagy regulators, and metabolic checkpoint sensors. While BECN1 is not in the provided list, other autophagy-related genes may be represented through indirect connections to metabolic state. The relationship between mitochondrial dysfunction and senescence is bidirectional; impaired mitochondrial quality control permits accumulation of dysfunctional mitochondria producing elevated reactive oxygen species (ROS), which drives DNA damage and senescence, while senescence simultaneously impairs mitophagy through S-nitrosylation of Parkin and reduced lysosomal capacity[35][64]. The transcription factor YAP1 appears in this context as well, with evidence suggesting that YAP activation prevents premature senescence of astrocytes and protects against cognitive decline in Alzheimer disease through CDK6 signaling[22][24]. The mitochondrial calcium accumulation program, involving ITPR2 and related calcium-handling proteins discussed above, directly intersects with senescence through activation of the mitochondrial permeability transition pore[35][64]. In astrocytoma, particularly in older patients where age-related cellular changes accumulate, dysregulation of mitochondrial quality control may shift astrocytes toward senescent states characterized by altered metabolism and SASP production that either opposes or supports tumor progression depending on specific context[21][35][64]. The FKBP5 protein, also in the provided list, encodes an immunophilin involved in protein folding and stress responses that interact with the HPA axis and may connect stress responses to mitochondrial health[15].\n\n## Program Integration and Cross-Talk Mechanisms\n\nThe individual gene programs identified above do not operate in isolation but rather exhibit extensive crosstalk and mutual regulation that enables astrocytes to integrate diverse environmental signals and coordinate complex behavioral responses[21][40][48]. The calcium signaling program directly regulates multiple downstream programs including gap junction communication (through CaMKII-dependent GJA1 phosphorylation), astrocyte reactivity (through calcineurin-NFAT signaling), and metabolic adaptation (through direct effects on mitochondrial metabolism)[22][40][64]. Growth factor signaling through NTRK2, NRG3, and related receptors intersects with YAP1-mediated transcriptional control and lipid metabolism programs to enable metabolic flexibility and proliferation in response to developmental and pathological signals[24][28]. The ion homeostasis program, centered on ATP1A2 and AQP4, exhibits bidirectional signaling with glutamate transport, as glutamate uptake drives sodium influx that activates ATP1A2, which both provides energy for continued glutamate transport and stimulates glycolysis and lactate production that feeds back to support neuronal energy metabolism[9][32][40]. The reactive astrocyte program encompasses transcriptional control through ID, YAP, and related factors while simultaneously engaging pattern recognition through TLR4 and metabolic reprogramming to support immune cell interactions and local tissue repair[14][40]. The cell adhesion and ECM interaction program operates bidirectionally with cytoskeletal organization, as integrin signaling through ITGA6 promotes process extension and migration through actin cytoskeleton remodeling coordinated by formin and Rho GTPase regulators[40][56][57]. In the specific context of astrocytoma, this integration of programs enables tumor cells to transition between different functional states, with some populations maintaining pro-inflammatory and metabolically supportive functions that promote tumor progression while others maintain more differentiated phenotypes or even retain some capacity for anti-tumor functions[21][28][52].\n\n## Astrocytoma-Specific Program Dysregulation and Malignant Transformation\n\nAstrocytoma development from normal astrocytes to infiltrating diffuse tumors involves progressive dysregulation of the gene programs outlined above, with different molecular subtypes showing distinct patterns of program activation and repression[26][28][29]. IDH-mutant astrocytomas, characterized by isocitrate dehydrogenase mutations that produce the oncometabolite 2-hydroxyglutarate, show particular dependence on altered metabolic programs including lipid metabolism and energy production[26][29]. The recent discovery that glioblastoma progression involves sequential mutations in TERT promoter, TP53, and PDGFRA that collectively drive transformation through activation of an INSM1-driven intermediate progenitor state suggests that astrocytoma similarly engages developmental transcriptional programs through dysregulation of YAP, ID, and related factors[28]. The presence of NTRK2 fusion genes in certain pediatric astrocytomas, driving constitutive receptor activation and sustained MAPK and PI3K signaling, highlights the pathogenic importance of growth factor signaling program dysregulation in specific molecular contexts[26]. Evidence that pericytes and surrounding stromal cells orchestrate substantial paracrine communication with tumor astrocytes, with pericyte depletion exacerbating tumor progression through altered immune cell recruitment and vascular barrier integrity, underscores the importance of cell adhesion and gap junction communication programs in astrocytoma pathogenesis[46][61]. The spatial transcriptomic profiling studies revealing distinct ECM expression signatures in glioblastoma versus normal brain and lower-grade astrocytoma emphasize that ECM interaction programs are substantially remodeled during malignant transformation[6][46][52].\n\n## Conclusion and Integrated Perspective\n\nThis comprehensive analysis identifies eleven distinct gene programs encoded by genes in the provided list that collectively govern critical aspects of astrocyte physiology in both health and disease. These programs encompass ion homeostasis and calcium signaling, glutamate metabolism and neurotransmitter handling, cytoskeletal dynamics and morphological control, cell adhesion and ECM interactions, gap junction communication, lipid metabolism and APOE signaling, reactive astrocyte and neuroinflammation responses, transcriptional control of differentiation and stemness, amino acid transport and metabolic flexibility, mitochondrial quality control and senescence, and finally the integrative cross-talk mechanisms enabling coordinated responses to complex microenvironmental signals. In the context of astrocytoma, dysregulation of these programs at multiple levels—through genetic alterations in core pathway components, epigenetic changes altering gene expression, and microenvironmental pressures selecting for advantageous cellular states—collectively drives transformation from normal astrocytes to infiltrating neoplastic cells. The presence of multiple genes from the input list that encode components of the same functional programs provides multiple entry points for understanding both the molecular mechanisms of astrocytoma development and potential therapeutic vulnerabilities. Future studies integrating this gene program-level perspective with single-cell transcriptomic and spatial analyses, proteomics, and metabolomic profiling will further refine understanding of how these programs coordinate in different astrocytoma molecular subtypes and how they respond to therapeutic interventions.\n\n---\n\n```json\n{\n  \"$schema\": \"http://json-schema.org/draft-07/schema#\",\n  \"context\": {\n    \"cell_type\": \"astrocytes\",\n    \"disease\": \"astrocytoma\",\n    \"tissue\": \"brain\"\n  },\n  \"input_genes\": [\n    \"FAM189A2\",\n    \"OGFRL1\",\n    \"MAP3K5\",\n    \"ITPR2\",\n    \"ETNPPL\",\n    \"NRG3\",\n    \"CD38\",\n    \"FMN2\",\n    \"LINC01088\",\n    \"KCNN3\",\n    \"DAAM2\",\n    \"AC002429.2\",\n    \"OBI1-AS1\",\n    \"NTRK2\",\n    \"SYTL4\",\n    \"WDR49\",\n    \"ADGRV1\",\n    \"LIFR\",\n    \"AQP4\",\n    \"ID3\",\n    \"OSBPL11\",\n    \"DPP10\",\n    \"SERPINI2\",\n    \"TLR4\",\n    \"NAA11\",\n    \"MGAT4C\",\n    \"AC026316.5\",\n    \"EEPD1\",\n    \"RASSF4\",\n    \"AL392086.3\",\n    \"SLC4A4\",\n    \"EDNRB\",\n    \"SLC39A11\",\n    \"ATP1A2\",\n    \"SLCO1C1\",\n    \"AHCYL2\",\n    \"SPON1\",\n    \"SLC1A3\",\n    \"GRAMD2B\",\n    \"DTNA\",\n    \"AC012405.1\",\n    \"NKAIN3\",\n    \"NTM\",\n    \"SLC14A1\",\n    \"DCLK2\",\n    \"DCLK1\",\n    \"ID4\",\n    \"AC124854.1\",\n    \"LINC01094\",\n    \"PCDH9\",\n    \"GABBR2\",\n    \"PARD3B\",\n    \"PDE8A\",\n    \"LRIG1\",\n    \"C5ORF64\",\n    \"RNF19A\",\n    \"SPARCL1\",\n    \"AC093535.1\",\n    \"FADS2\",\n    \"PLEKHA5\",\n    \"ASTN2\",\n    \"ADAMTS9\",\n    \"AC073941.1\",\n    \"SLC24A4\",\n    \"PAPPA\",\n    \"AC068587.4\",\n    \"FARP1\",\n    \"SORL1\",\n    \"ARHGAP26\",\n    \"CADPS\",\n    \"ST3GAL6\",\n    \"ITPKB\",\n    \"GABRB1\",\n    \"FAM107A\",\n    \"MIR99AHG\",\n    \"ANK2\",\n    \"AC107223.1\",\n    \"PPP2R2B\",\n    \"LPL\",\n    \"AL589935.1\",\n    \"MRVI1\",\n    \"TNIK\",\n    \"AL160272.1\",\n    \"AC016766.1\",\n    \"RANBP3L\",\n    \"ARHGEF4\",\n    \"ADCY2\",\n    \"NPL\",\n    \"KCNQ5\",\n    \"AC079352.1\",\n    \"LIX1\",\n    \"APOE\",\n    \"SLC25A48\",\n    \"ADCYAP1R1\",\n    \"AHCYL1\",\n    \"RASL12\",\n    \"GINS3\",\n    \"PTPRG\",\n    \"AL096709.1\",\n    \"BMP2K\",\n    \"MCF2L2\",\n    \"RBMS3\",\n    \"SLCO3A1\",\n    \"AL445426.1\",\n    \"CARMIL1\",\n    \"CACNA2D3\",\n    \"CDHR3\",\n    \"NAV3\",\n    \"UTRN\",\n    \"NRP2\",\n    \"DNAH7\",\n    \"KIAA1671\",\n    \"HPSE2\",\n    \"COL4A5\",\n    \"AC083864.5\",\n    \"L3MBTL4\",\n    \"AC092131.1\",\n    \"PCSK6\",\n    \"AC097450.1\",\n    \"ANOS1\",\n    \"SYNPO2\",\n    \"LINC00836\",\n    \"MAPK4\",\n    \"AL365259.1\",\n    \"WNK2\",\n    \"LMO3\",\n    \"SSBP2\",\n    \"SLC1A4\",\n    \"PPP2R5A\",\n    \"LINC00299\",\n    \"SLC15A2\",\n    \"CNTN1\",\n    \"FKBP5\",\n    \"GREB1L\",\n    \"LUZP2\",\n    \"MAP7\",\n    \"AC023095.1\",\n    \"IGFBP7\",\n    \"ALDH1A1\",\n    \"GRAMD1C\",\n    \"RHBDL3\",\n    \"DAPK1\",\n    \"LINC02058\",\n    \"TENM4\",\n    \"RTN1\",\n    \"LINC01138\",\n    \"GLUD1\",\n    \"NEBL\",\n    \"LINC01117\",\n    \"AC092691.1\",\n    \"TJP2\",\n    \"PCDH9-AS2\",\n    \"YAP1\",\n    \"ABCC9\",\n    \"LAMA1\",\n    \"AL137024.1\",\n    \"ERBB4\",\n    \"ADRA1A\",\n    \"MYBPC1\",\n    \"NT5DC3\",\n    \"AQP1\",\n    \"NKAIN4\",\n    \"ARAP2\",\n    \"RHOB\",\n    \"AQP4-AS1\",\n    \"CDH20\",\n    \"RGMA\",\n    \"OSGIN2\",\n    \"PRKG1\",\n    \"MROH7\",\n    \"PRRX1\",\n    \"MAST4\",\n    \"CHL1\",\n    \"PAPLN\",\n    \"OSBPL3\",\n    \"RFX4\",\n    \"CD44\",\n    \"ATP13A4\",\n    \"COL5A3\",\n    \"ITGA6\",\n    \"DOCK7\",\n    \"CPE\",\n    \"DPF3\",\n    \"ZNF521\",\n    \"DHRS3\",\n    \"AC006148.1\",\n    \"LMNTD1\",\n    \"AC092924.2\",\n    \"LHFPL6\",\n    \"AC024145.1\",\n    \"LIMCH1\",\n    \"SRPX2\",\n    \"AL590999.1\",\n    \"ADCY8\",\n    \"AC008957.2\",\n    \"TTYH2\",\n    \"GJA1\",\n    \"SHROOM3\",\n    \"USH1C\",\n    \"AC007262.2\"\n  ],\n  \"programs\": [\n    {\n      \"program_name\": \"Ion Homeostasis and Intracellular Calcium Regulation\",\n      \"description\": \"Astrocytes maintain precise extracellular ion concentrations and intracellular calcium dynamics through coordinated action of aquaporins, ion pumps, channels, and calcium-release machinery. ATP1A2 encodes the Na+/K+-ATPase critical for maintaining electrochemical gradients. AQP4 facilitates rapid water transport across membranes, particularly at perivascular endfeet. KCNN3 and KCNQ5 are potassium channels regulating membrane potential and calcium-dependent processes. ITPR2 gates IP3-mediated calcium release from the endoplasmic reticulum. SLC4A4 encodes the sodium bicarbonate cotransporter supporting pH regulation and osmotic balance. This program is essential for astrocyte volume control, glutamate uptake coupling, and responses to neuronal activity.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Sodium-potassium pump function and electrochemical gradient maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Describes ATP1A2 role in astrocyte energy consumption and function\"\n            },\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Details ATP1A2 coupling to glutamate uptake and metabolism in astrocytes\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses astrocytic Na+/K+ ATPase in neurovascular coupling\"\n            }\n          ],\n          \"genes\": [\n            \"ATP1A2\"\n          ]\n        },\n        {\n          \"name\": \"Water transport and osmotic regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"3\",\n              \"notes\": \"Details AQP4 isoforms and orthogonal array formation at astrocyte endfeet\"\n            },\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Describes AQP4 roles in blood-brain barrier function and intracellular water transport\"\n            },\n            {\n              \"source_id\": \"43\",\n              \"notes\": \"Demonstrates AQP4 function in BBB model systems\"\n            }\n          ],\n          \"genes\": [\n            \"AQP4\",\n            \"AQP1\"\n          ]\n        },\n        {\n          \"name\": \"Potassium channel-mediated membrane potential control\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Discusses KCNN3 and related potassium channels in neuronal and glial function\"\n            },\n            {\n              \"source_id\": \"57\",\n              \"notes\": \"Details potassium channel roles in astrocyte excitability\"\n            }\n          ],\n          \"genes\": [\n            \"KCNN3\",\n            \"KCNQ5\",\n            \"ABCC9\"\n          ]\n        },\n        {\n          \"name\": \"IP3-mediated intracellular calcium release\",\n          \"citations\": [\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"Describes ITPR2 role in ammonia-induced glutamine synthetase downregulation through Hippo pathway\"\n            },\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Details ITPR2-mediated calcium accumulation and senescence induction\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses calcium signaling in astrocyte-mediated neurovascular coupling\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        },\n        {\n          \"name\": \"Bicarbonate transport and pH regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses multiple bicarbonate transporters in astrocyte pH control\"\n            }\n          ],\n          \"genes\": [\n            \"SLC4A4\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Aquaporin-water channel complex at astrocytic endfeet\",\n          \"citations\": [\n            {\n              \"source_id\": \"3\",\n              \"notes\": \"Details AQP4-M23 orthogonal array assembly and perivascular localization\"\n            },\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Describes perivascular astrocyte endfeet wrapping around capillaries\"\n            }\n          ],\n          \"genes\": [\n            \"AQP4\",\n            \"DTNA\"\n          ]\n        },\n        {\n          \"name\": \"Sodium-potassium ATPase pump complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Details ATP1A2 in astrocyte metabolism\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses ATPase localization and interactions in neurovascular complexes\"\n            }\n          ],\n          \"genes\": [\n            \"ATP1A2\"\n          ]\n        },\n        {\n          \"name\": \"Potassium channel assembly\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Discusses potassium channel function in cell excitability\"\n            }\n          ],\n          \"genes\": [\n            \"KCNN3\",\n            \"KCNQ5\"\n          ]\n        },\n        {\n          \"name\": \"ER-mitochondria calcium transfer zones\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Details mitochondrial-ER contact sites and calcium transfer machinery\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Discusses MERCS in calcium homeostasis and senescence\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Rapid astrocyte volume changes enabling process extension and retraction\",\n        \"Maintenance of extracellular potassium homeostasis critical for neuronal excitability\",\n        \"Coupling of glutamate uptake to ATP hydrolysis and lactate production\",\n        \"Blood-brain barrier integrity through perivascular endfeet water transport\",\n        \"Coordinated calcium signaling regulating astrocyte metabolic state and reactivity\",\n        \"Disruption of ion homeostasis in tumor-derived astrocytes enabling migration and invasion\"\n      ],\n      \"evidence_summary\": \"Multiple genes from the input list encode key components of astrocyte ion homeostasis machinery. ATP1A2 serves as an energetic hub linking ion pumping to glutamate transport and metabolism. AQP4 is essential for perivascular astrocyte function and BBB maintenance, with distinct isoforms affecting orthogonal array formation. Potassium channels KCNN3 and KCNQ5 regulate membrane potential and calcium-dependent processes. ITPR2 mediates IP3-driven calcium release from ER stores, with dysregulation contributing to senescence and pathological calcium accumulation. SLC4A4 completes the osmotic regulation circuit through bicarbonate transport. In astrocytoma, disrupted ion homeostasis likely facilitates tumor cell migration through enhanced volume plasticity and enables constitutive signaling through altered calcium dynamics.\",\n      \"significance_score\": 0.92,\n      \"citations\": [\n        {\n          \"source_id\": \"3\",\n          \"notes\": \"Describes AQP4 isoforms and function in astrocytes\"\n        },\n        {\n          \"source_id\": \"9\",\n          \"notes\": \"Comprehensive review of astrocyte ion homeostasis and BBB function\"\n        },\n        {\n          \"source_id\": \"32\",\n          \"notes\": \"Details astrocyte metabolism and ion pump coupling\"\n        },\n        {\n          \"source_id\": \"40\",\n          \"notes\": \"Discusses astrocyte ion homeostasis in neurovascular coupling\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"ATP1A2\",\n        \"AQP4\",\n        \"KCNN3\",\n        \"KCNQ5\",\n        \"ITPR2\",\n        \"SLC4A4\",\n        \"AQP1\",\n        \"ABCC9\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"SERCA2/ATP2A2 (calcium reuptake into ER)\",\n          \"NCX (sodium-calcium exchanger)\",\n          \"MCU (mitochondrial calcium uniporter)\",\n          \"NKCC1/SLC12A2 (Na-K-2Cl cotransporter)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"40\",\n            \"notes\": \"Discusses multiple calcium handling systems beyond those in input list\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Glutamate Metabolism and Synaptic Homeostasis\",\n      \"description\": \"Astrocytes participate in the glutamate-glutamine cycle essential for excitatory neurotransmission and neuronal survival. SLC1A3 encodes the primary high-affinity glutamate transporter responsible for synaptic glutamate clearance. SLC1A4 (ASCT2) enables glutamate uptake via cation-independent amino acid exchange. GLUD1 catalyzes bidirectional conversion between glutamate and α-ketoglutarate, linking amino acid metabolism to tricarboxylic acid cycle. Additional transporters including SLC15A2, SLC24A4, SLC14A1, and SLC39A11 enable metabolic flexibility and nutrient sensing. ITPKB regulates inositol phosphate metabolism connected to calcium signaling downstream of glutamate receptor activation. This program directly supports neuronal metabolism, prevents excitotoxicity, and maintains synaptic plasticity.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"High-affinity synaptic glutamate clearance\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Describes SLC1A3 as primary glutamate transporter in astrocytes\"\n            },\n            {\n              \"source_id\": \"10\",\n              \"notes\": \"Details SLC1A3 function and genetic variations affecting expression\"\n            },\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Discusses glutamate transport in astrocyte metabolism\"\n            }\n          ],\n          \"genes\": [\n            \"SLC1A3\"\n          ]\n        },\n        {\n          \"name\": \"Glutamate-glutamine cycle and transamination\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Comprehensive description of glutamate-glutamine cycle in astrocytes\"\n            },\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Details glutamine synthetase and cycle dynamics in astrocyte metabolism\"\n            }\n          ],\n          \"genes\": [\n            \"GLUD1\",\n            \"SLC1A3\"\n          ]\n        },\n        {\n          \"name\": \"Amino acid exchange and branched-chain amino acid handling\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Discusses astrocyte amino acid transport and metabolism\"\n            },\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Details amino acid transporters in astrocyte metabolic flexibility\"\n            }\n          ],\n          \"genes\": [\n            \"SLC1A4\",\n            \"SLC15A2\",\n            \"SLC24A4\",\n            \"SLC14A1\",\n            \"SLC39A11\",\n            \"SLC25A48\"\n          ]\n        },\n        {\n          \"name\": \"Inositol phosphate metabolism and calcium signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"Discusses inositol signaling in astrocyte regulation\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Details IP3 signaling in astrocyte calcium dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"ITPKB\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Synaptic glutamate transporter complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Describes SLC1A3 trafficking and localization to astrocyte processes\"\n            }\n          ],\n          \"genes\": [\n            \"SLC1A3\"\n          ]\n        },\n        {\n          \"name\": \"Tricarboxylic acid cycle glutamate oxidation capacity\",\n          \"citations\": [\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Details GLUD1 in TCA cycle and energy metabolism\"\n            }\n          ],\n          \"genes\": [\n            \"GLUD1\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Prevention of excitotoxicity through rapid synaptic glutamate clearance\",\n        \"Support of neuronal GABA synthesis through glutamate recycling\",\n        \"Coupling of glutamate uptake to energy production and lactate generation\",\n        \"Integration of amino acid availability with metabolic state\",\n        \"Maintenance of proper excitatory-inhibitory balance at synapses\",\n        \"Enhanced glutamate uptake enabling metabolic support in astrocytoma supporting tumor-associated neuroinflammation\"\n      ],\n      \"evidence_summary\": \"The glutamate metabolism program is centered on SLC1A3-mediated high-affinity glutamate clearance coupled to metabolic processing through GLUD1 and the glutamate-glutamine cycle. Multiple additional amino acid transporters enable metabolic flexibility and nutrient sensing. In normal astrocytes, this program prevents excitotoxicity and supports neuronal metabolism. In astrocytoma, dysregulation of this program through altered expression of SLC1A3 and metabolic enzymes can either impair anti-tumor glutamate buffering or enhance metabolic support of malignant cells depending on specific molecular context and tumor stage.\",\n      \"significance_score\": 0.88,\n      \"citations\": [\n        {\n          \"source_id\": \"9\",\n          \"notes\": \"Comprehensive discussion of glutamate-glutamine cycle\"\n        },\n        {\n          \"source_id\": \"10\",\n          \"notes\": \"Details SLC1A3 genetics and astrocyte function\"\n        },\n        {\n          \"source_id\": \"32\",\n          \"notes\": \"Integrates glutamate metabolism with astrocyte energetics\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"SLC1A3\",\n        \"SLC1A4\",\n        \"GLUD1\",\n        \"SLC15A2\",\n        \"SLC24A4\",\n        \"SLC14A1\",\n        \"SLC39A11\",\n        \"SLC25A48\",\n        \"ITPKB\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"GLUL/GS (glutamine synthetase - essential for glutamine production)\",\n          \"GLNS (glutaminase - converts glutamine back to glutamate)\",\n          \"GLS2 (glutaminase 2)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"9\",\n            \"notes\": \"Glutamine synthetase and glutaminase are critical components of glutamate-glutamine cycle\"\n          },\n          {\n            \"source_id\": \"22\",\n            \"notes\": \"Details glutamine synthetase regulation and ammonia sensitivity\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Cytoskeletal Dynamics and Process Motility\",\n      \"description\": \"Astrocytes maintain highly elaborate branched morphologies with dynamic process extension and retraction through coordinated regulation of actin polymerization and Rho GTPase signaling. Formin family proteins FMN2 and DAAM2 nucleate linear actin filament arrays critical for filopodia and process formation. Rho GTPase regulators ARHGAP26 and ARHGEF4 control Rac1 and Rho activation states governing process growth versus retraction. Structural proteins ASTN2, NEBL, and MAP7 stabilize microtubules and actin bundles. LIMCH1 provides additional actin-binding capacity. SHROOM3 mediates actin bundle organization and cell shape changes. DTNA (dystrophin-associated protein A) anchors cytoskeleton to membrane proteins and ECM. This program enables astrocytes to extend processes to contact neurons and vasculature while maintaining flexibility for migration and morphological adaptation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Actin polymerization and formin-mediated filament nucleation\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Detailed discussion of formins FMN2 and DAAM2 in axon guidance and branching\"\n            },\n            {\n              \"source_id\": \"57\",\n              \"notes\": \"Discusses actin dynamics in astrocyte process extension\"\n            }\n          ],\n          \"genes\": [\n            \"FMN2\",\n            \"DAAM2\"\n          ]\n        },\n        {\n          \"name\": \"Rho GTPase regulation and process extension-retraction cycling\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Comprehensive discussion of Rho GTPase signaling in axon branching\"\n            },\n            {\n              \"source_id\": \"57\",\n              \"notes\": \"Details Plexin-B1 regulation of Rac1 and astrocyte process dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"ARHGAP26\",\n            \"ARHGEF4\",\n            \"MCF2L2\",\n            \"RHOB\"\n          ]\n        },\n        {\n          \"name\": \"Microtubule stabilization and organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Discusses MAP proteins in axon organization\"\n            }\n          ],\n          \"genes\": [\n            \"MAP7\",\n            \"NEBL\"\n          ]\n        },\n        {\n          \"name\": \"Actin bundle assembly and cell shape organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"57\",\n              \"notes\": \"Details SHROOM3 role in actin bundle assembly and astrocyte morphology\"\n            }\n          ],\n          \"genes\": [\n            \"SHROOM3\",\n            \"LIMCH1\"\n          ]\n        },\n        {\n          \"name\": \"Cytoskeleton-membrane protein anchoring\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Discusses dystrophin and associated protein complex at astrocyte endfeet\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Details structural anchoring at perivascular endfeet\"\n            }\n          ],\n          \"genes\": [\n            \"DTNA\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Linear actin filament arrays and filopodia\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Describes formin-nucleated linear actin in filopodia formation\"\n            },\n            {\n              \"source_id\": \"57\",\n              \"notes\": \"Details process filopodia in astrocyte dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"FMN2\",\n            \"DAAM2\"\n          ]\n        },\n        {\n          \"name\": \"Actin bundle networks\",\n          \"citations\": [\n            {\n              \"source_id\": \"57\",\n              \"notes\": \"Discusses SHROOM3-mediated actin bundle organization\"\n            }\n          ],\n          \"genes\": [\n            \"SHROOM3\",\n            \"LIMCH1\",\n            \"NEBL\"\n          ]\n        },\n        {\n          \"name\": \"Microtubule cytoskeleton\",\n          \"citations\": [\n            {\n              \"source_id\": \"56\",\n              \"notes\": \"Details MAP7 role in microtubule organization\"\n            }\n          ],\n          \"genes\": [\n            \"MAP7\"\n          ]\n        },\n        {\n          \"name\": \"Dystrophin-associated protein complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"9\",\n              \"notes\": \"Describes DAP complex at astrocyte endfeet\"\n            }\n          ],\n          \"genes\": [\n            \"DTNA\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Dynamic extension and retraction of astrocytic processes enabling rapid response to neuronal activity\",\n        \"Formation and maintenance of astrocyte-neuron synaptic contacts\",\n        \"Perivascular endfeet stability and BBB structural integrity\",\n        \"Coordinated astrocyte alignment in tissue organization\",\n        \"Actin-based cell migration and invasion in tumor contexts\",\n        \"Enhanced process plasticity facilitating astrocytoma cell invasion through brain parenchyma\"\n      ],\n      \"evidence_summary\": \"The cytoskeletal dynamics program comprises formin-mediated actin polymerization through FMN2 and DAAM2, Rho GTPase regulation through ARHGAP26 and ARHGEF4, and structural stabilization through SHROOM3, LIMCH1, and NEBL. Recent work demonstrates that loss of Plexin-B1 impairs astrocyte process dynamics, resulting in reduced mobility, abnormal clustering, and altered membrane fragmentation, underscoring the critical role of Rho signaling regulation in maintaining astrocyte morphological plasticity. DTNA provides membrane anchoring. In astrocytoma, enhanced cytoskeletal plasticity likely enables tumor cell invasion through brain parenchyma and supports the morphological heterogeneity characteristic of infiltrating tumors.\",\n      \"significance_score\": 0.85,\n      \"citations\": [\n        {\n          \"source_id\": \"56\",\n          \"notes\": \"Comprehensive analysis of formin and Rho signaling in axon branching\"\n        },\n        {\n          \"source_id\": \"57\",\n          \"notes\": \"Detailed study of astrocyte process dynamics and Plexin-B1 regulation\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"FMN2\",\n        \"DAAM2\",\n        \"ARHGAP26\",\n        \"ARHGEF4\",\n        \"MCF2L2\",\n        \"RHOB\",\n        \"SHROOM3\",\n        \"LIMCH1\",\n        \"NEBL\",\n        \"MAP7\",\n        \"DTNA\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"Rac1, RhoA, Cdc42 (Rho GTPases - effector targets)\",\n          \"Cofilin (actin filament severing)\",\n          \"Profilin (actin monomer sequestration)\",\n          \"Arp2/3 complex (branched actin nucleation)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"56\",\n            \"notes\": \"Discusses Rac1 activation by Trio as critical for branching\"\n          },\n          {\n            \"source_id\": \"57\",\n            \"notes\": \"Mentions Rac1 downstream effects on actin dynamics\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Cell Adhesion and Extracellular Matrix Interactions\",\n      \"description\": \"Astrocytes embedded within complex brain extracellular matrix maintain extensive cell-cell and cell-ECM contacts essential for tissue architecture and intercellular signaling. Protocadherin-9 (PCDH9) and cadherin-20 (CDH20) mediate cell-cell adhesion. Integrin ITGA6 binds laminin and other ECM ligands, transducing bidirectional signals governing astrocyte behavior. ADAMTS9 remodels ECM through proteolytic processing. ECM proteins expressed by astrocytes include SPARCL1 (SPARC-like protein 1), LAMA1 (laminin alpha-1), and COL4A5 (collagen type IV alpha-5 chain). The program maintains basement membrane integrity, supports glial scarring responses, and facilitates cell migration through coordinated adhesion modulation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Cadherin-mediated cell-cell adhesion\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses cadherin roles in astrocyte cell-cell interactions\"\n            }\n          ],\n          \"genes\": [\n            \"PCDH9\",\n            \"CDH20\",\n            \"CHL1\"\n          ]\n        },\n        {\n          \"name\": \"Integrin-ECM ligand binding and signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses integrin signaling in astrocyte adhesion\"\n            },\n            {\n              \"source_id\": \"46\",\n              \"notes\": \"Details integrin signaling in pericyte-glioma interactions\"\n            }\n          ],\n          \"genes\": [\n            \"ITGA6\"\n          ]\n        },\n        {\n          \"name\": \"ECM proteolysis and remodeling\",\n          \"citations\": [\n            {\n              \"source_id\": \"6\",\n              \"notes\": \"Comprehensive spatial transcriptomic analysis of ECM genes in GBM\"\n            }\n          ],\n          \"genes\": [\n            \"ADAMTS9\",\n            \"HPSE2\"\n          ]\n        },\n        {\n          \"name\": \"Basement membrane protein production\",\n          \"citations\": [\n            {\n              \"source_id\": \"6\",\n              \"notes\": \"Discusses ECM protein expression in gliomas\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Details basement membrane organization at BBB\"\n            },\n            {\n              \"source_id\": \"43\",\n              \"notes\": \"Shows basement membrane assembly in 3D BBB models\"\n            }\n          ],\n          \"genes\": [\n            \"LAMA1\",\n            \"COL4A5\",\n            \"COL5A3\"\n          ]\n        },\n        {\n          \"name\": \"SPARC protein expression and ECM organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"6\",\n              \"notes\": \"SPARC-like proteins in ECM remodeling and tumor biology\"\n            }\n          ],\n          \"genes\": [\n            \"SPARCL1\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Cell-cell adhesion complexes\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses cadherin and related adhesion protein complexes\"\n            }\n          ],\n          \"genes\": [\n            \"PCDH9\",\n            \"CDH20\"\n          ]\n        },\n        {\n          \"name\": \"Integrin-focal adhesion complexes\",\n          \"citations\": [\n            {\n              \"source_id\": \"46\",\n              \"notes\": \"Details focal adhesion dynamics in glioma cells\"\n            }\n          ],\n          \"genes\": [\n            \"ITGA6\"\n          ]\n        },\n        {\n          \"name\": \"Basement membrane protein networks\",\n          \"citations\": [\n            {\n              \"source_id\": \"6\",\n              \"notes\": \"Describes basement membrane composition and alterations in gliomas\"\n            },\n            {\n              \"source_id\": \"43\",\n              \"notes\": \"Shows COL4 and related proteins in BBB basement membrane\"\n            }\n          ],\n          \"genes\": [\n            \"LAMA1\",\n            \"COL4A5\",\n            \"COL5A3\",\n            \"SPARCL1\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Maintenance of tissue architecture through coordinated cell-cell and cell-ECM contacts\",\n        \"Bidirectional signaling through integrin-ECM interactions governing cell behavior\",\n        \"Selective ECM remodeling enabling cell migration while maintaining tissue integrity\",\n        \"Basement membrane assembly and maintenance at blood-brain barrier\",\n        \"Astrocyte reactivity-associated ECM changes supporting glial scar formation\",\n        \"Enhanced ECM remodeling and reduced adhesion in invasive astrocytoma enabling tumor cell migration\"\n      ],\n      \"evidence_summary\": \"The cell adhesion program integrates cadherin-mediated cell-cell contacts (PCDH9, CDH20) with integrin-ECM interactions (ITGA6) and ECM protein production (LAMA1, COL4A5, SPARCL1). ADAMTS9 provides proteolytic ECM remodeling capacity. Recent spatial transcriptomic profiling of glioblastoma reveals substantial alterations in ECM composition compared to lower-grade tumors and normal brain, with differential expression of ECM genes in tumor versus stromal compartments suggesting coordinated remodeling programs during malignant transformation. In astrocytoma, dysregulation of this program through altered adhesion or proteolytic activity facilitates tumor cell invasion while simultaneously disrupting normal astrocyte-ECM interactions that support tissue homeostasis.\",\n      \"significance_score\": 0.82,\n      \"citations\": [\n        {\n          \"source_id\": \"6\",\n          \"notes\": \"Comprehensive spatial transcriptomic analysis of ECM in gliomas\"\n        },\n        {\n          \"source_id\": \"40\",\n          \"notes\": \"Discusses astrocyte adhesion and ECM interactions\"\n        },\n        {\n          \"source_id\": \"46\",\n          \"notes\": \"Details integrin signaling in tumor microenvironment\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"PCDH9\",\n        \"CDH20\",\n        \"ITGA6\",\n        \"ADAMTS9\",\n        \"SPARCL1\",\n        \"LAMA1\",\n        \"COL4A5\",\n        \"COL5A3\",\n        \"CHL1\",\n        \"HPSE2\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"E-cadherin/CDH1 (additional cadherin in some astrocyte contexts)\",\n          \"N-cadherin/CDH2 (cadherin in some astrocytes)\",\n          \"Laminin beta chains (LAMB1, LAMB3)\",\n          \"Nidogen (ECM cross-linking protein)\",\n          \"Perlecan (heparan sulfate proteoglycan)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"6\",\n            \"notes\": \"Lists additional ECM proteins altered in gliomas\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Gap Junction Communication and Astrocyte Network Integration\",\n      \"description\": \"Astrocytes form extensive electrical and metabolic coupling networks through gap junction channels containing connexin-43 (encoded by GJA1), enabling synchronized responses to neuronal activity and coordinated regulation of the local microenvironment. GJA1 oligomerizes to form gap junctions permeable to ions and small molecules including ATP, glucose, and amino acids. Gap junction formation and stability are regulated through post-translational modification and transcriptional control. LRIG1 may provide regulatory input to gap junction function through its role in EGFR signaling modulation. The coupled network enables rapid astrocyte responses to heterogeneous inputs and supports metabolic coordination between neighboring cells.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Connexin-43 gap junction channel assembly and regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses GJA1 regulation and dysfunction in disease\"\n            },\n            {\n              \"source_id\": \"62\",\n              \"notes\": \"Describes GJA1 gap junction composition and function\"\n            }\n          ],\n          \"genes\": [\n            \"GJA1\"\n          ]\n        },\n        {\n          \"name\": \"Small molecule and ion transfer through gap junctions\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Details metabolite transfer through astrocyte gap junctions\"\n            },\n            {\n              \"source_id\": \"62\",\n              \"notes\": \"Describes gap junction permeability\"\n            }\n          ],\n          \"genes\": [\n            \"GJA1\"\n          ]\n        },\n        {\n          \"name\": \"Gap junction regulation by kinase phosphorylation\",\n          \"citations\": [\n            {\n              \"source_id\": \"62\",\n              \"notes\": \"Discusses AKT-dependent GJA1 phosphorylation and internalization\"\n            },\n            {\n              \"source_id\": \"65\",\n              \"notes\": \"Details mTOR inhibition of gap junction dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"GJA1\"\n          ]\n        },\n        {\n          \"name\": \"LRIG1-mediated growth factor signaling regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses LRIG1 in astrocyte signaling\"\n            }\n          ],\n          \"genes\": [\n            \"LRIG1\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Gap junction channels and connexin-43 oligomers\",\n          \"citations\": [\n            {\n              \"source_id\": \"62\",\n              \"notes\": \"Describes connexin-43 hexamer and higher-order assembly\"\n            }\n          ],\n          \"genes\": [\n            \"GJA1\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Coordinated astrocyte responses to neuronal activity through electrical coupling\",\n        \"Metabolic support to neighboring astrocytes through ATP and metabolite sharing\",\n        \"Synchronized calcium signaling across astrocyte networks\",\n        \"Reduced gap junctional communication in reactive and tumor-associated astrocytes disrupting coordinated responses\",\n        \"Enhanced tumor cell growth through altered paracrine signaling between tumor and normal astrocytes\"\n      ],\n      \"evidence_summary\": \"GJA1 represents the primary connexin in astrocyte gap junctions, forming channels permeable to ions and metabolites that enable astrocyte network integration. Gap junction function is dynamically regulated through post-translational modification and transcriptional control in response to signaling cascades. In reactive astrocytes and potentially in astrocytoma-associated astrocytes, gap junction expression and function are frequently altered, disrupting the coordinated astrocyte network responses essential for normal CNS homeostasis. LRIG1 may modulate this program through indirect effects on growth factor signaling. While specific studies of gap junction dysfunction in astrocytoma are limited, the known loss of gap junctional coupling in reactive glial states suggests this program is dysregulated during malignant transformation.\",\n      \"significance_score\": 0.68,\n      \"citations\": [\n        {\n          \"source_id\": \"40\",\n          \"notes\": \"Comprehensive discussion of astrocyte gap junctions\"\n        },\n        {\n          \"source_id\": \"62\",\n          \"notes\": \"Detailed description of connexin-43 biology\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"GJA1\",\n        \"LRIG1\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"Pannexins (alternative channel proteins)\",\n          \"ZO-1 and other PDZ proteins (scaffolding of gap junctions)\",\n          \"Src family kinases (phosphorylation of GJA1)\",\n          \"PKC (protein kinase C, GJA1 regulation)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"40\",\n            \"notes\": \"Discusses additional regulators of gap junction function\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Lipid Metabolism and Apolipoprotein-E Signaling\",\n      \"description\": \"Astrocytes play central roles in lipid homeostasis and cholesterol delivery to neurons, with astrocyte-derived APOE being the predominant cholesterol carrier in the central nervous system. APOE is synthesized by astrocytes and transported in circulating CSF and parenchymal interstitium. Three common isoforms (ε2, ε3, ε4) differ structurally and influence lipid binding and receptor interactions, with ε4 conferring increased Alzheimer disease risk. LPL catalyzes hydrolysis of triglycerides in circulating lipoproteins. FADS2 enables synthesis of polyunsaturated fatty acids. OSBPL11 and OSBPL3 sense intracellular cholesterol levels and regulate transcriptional control of lipogenic programs. The program links metabolic state to transcriptional control through lipid-activated transcription factors.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Apolipoprotein E synthesis and CSF transport\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses APOE synthesis by astrocytes and ε4 effects on neuroinflammation\"\n            },\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Reviews APOE roles in lipid metabolism and neurodegeneration\"\n            }\n          ],\n          \"genes\": [\n            \"APOE\"\n          ]\n        },\n        {\n          \"name\": \"Lipoprotein lipase-mediated triglyceride hydrolysis\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Discusses LPL in lipid metabolism\"\n            },\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Details LPL in astrocyte metabolism\"\n            }\n          ],\n          \"genes\": [\n            \"LPL\"\n          ]\n        },\n        {\n          \"name\": \"Polyunsaturated fatty acid synthesis\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Discusses FADS2 role in lipid synthesis\"\n            }\n          ],\n          \"genes\": [\n            \"FADS2\"\n          ]\n        },\n        {\n          \"name\": \"Oxysterol sensing and lipid metabolism regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Discusses oxysterol-binding proteins in lipid homeostasis\"\n            }\n          ],\n          \"genes\": [\n            \"OSBPL11\",\n            \"OSBPL3\"\n          ]\n        },\n        {\n          \"name\": \"YAP1-SREBP1 lipogenesis regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Details YAP control of lipid metabolism through SREBP1\"\n            }\n          ],\n          \"genes\": [\n            \"YAP1\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Apolipoprotein E particles\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Describes APOE particle composition and function\"\n            }\n          ],\n          \"genes\": [\n            \"APOE\"\n          ]\n        },\n        {\n          \"name\": \"Lipid droplets in astrocytes\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Discusses astrocyte lipid droplets and their pathological accumulation\"\n            }\n          ],\n          \"genes\": [\n            \"APOE\",\n            \"LPL\",\n            \"OSBPL11\",\n            \"OSBPL3\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Maintenance of neuronal lipid homeostasis through APOE-mediated cholesterol delivery\",\n        \"APOE ε4-associated potentiation of astrocyte-mediated neuroinflammation\",\n        \"Flexible metabolic adaptation between oxidative phosphorylation and lipogenesis\",\n        \"Sensing of metabolic state through oxysterol-binding protein interactions\",\n        \"Enhanced lipid metabolism supporting tumor cell membrane biogenesis in astrocytoma\",\n        \"Dysregulated APOE signaling contributing to tumor microenvironment remodeling\"\n      ],\n      \"evidence_summary\": \"APOE synthesis by astrocytes provides cholesterol delivery to neurons; the ε4 isoform associates with increased neuroinflammatory responses and Alzheimer disease risk. LPL enables local triglyceride processing. FADS2 supports polyunsaturated fatty acid synthesis critical for membrane composition and signaling. OSBPL11 and OSBPL3 function as lipid sensors regulating transcriptional programs in response to cholesterol availability. Recent evidence reveals that YAP1, through interaction with SREBP1, regulates astrocytic lipogenesis and potentially supports neuroprotection through metabolic adaptation. In astrocytoma, lipid metabolism dysregulation may support tumor cell proliferation through enhanced membrane biogenesis and altered metabolic support from tumor-associated astrocytes, while APOE ε4 status may influence the inflammatory microenvironment surrounding tumors.\",\n      \"significance_score\": 0.80,\n      \"citations\": [\n        {\n          \"source_id\": \"14\",\n          \"notes\": \"Comprehensive discussion of APOE ε4 and astrocyte reactivity\"\n        },\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Reviews lipid metabolism and microglial lipid droplets with implications for astrocyte lipid handling\"\n        },\n        {\n          \"source_id\": \"24\",\n          \"notes\": \"Details YAP-SREBP1 lipogenesis pathway\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"APOE\",\n        \"LPL\",\n        \"FADS2\",\n        \"OSBPL11\",\n        \"OSBPL3\",\n        \"YAP1\",\n        \"AHCYL1\",\n        \"AHCYL2\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"SREBP2 (sterol regulatory element-binding protein 2)\",\n          \"LDLR (low-density lipoprotein receptor)\",\n          \"LRP1 (LDL receptor-related protein 1)\",\n          \"PCSK9 (LDLR regulator)\",\n          \"Apolipoprotein receptors (ApoER2, LDL-RP/LRP1)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"14\",\n            \"notes\": \"Discusses APOE receptor interactions\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Reactive Astrocyte Transformation and Neuroinflammation\",\n      \"description\": \"In response to injury, infection, or disease, astrocytes undergo reactive transformation characterized by morphological changes, altered gene expression, and pro-inflammatory signaling. This program encompasses surface antigen upregulation (CD44, CD38), pattern recognition receptor signaling (TLR4), inhibition of differentiation (ID3, ID4), and transcriptional control of inflammatory responses (YAP1, RFX4). CD44 serves as a hyaluronic acid receptor upregulated on reactive astrocytes, facilitating immune cell interactions. CD38, a NAD-consuming enzyme, is upregulated in reactive glial cells and contributes to altered metabolic state. TLR4 recognizes pathogen-associated and damage-associated molecular patterns, driving NF-κB-dependent pro-inflammatory signaling. ID3 and ID4 promote proliferation while antagonizing differentiation. YAP1 simultaneously drives both inflammatory responses and metabolic adaptation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Hyaluronic acid receptor-mediated immune cell interaction\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses CD44 upregulation in reactive astrocytes\"\n            }\n          ],\n          \"genes\": [\n            \"CD44\"\n          ]\n        },\n        {\n          \"name\": \"NAD+ metabolism and cellular energetics in reactive astrocytes\",\n          \"citations\": [\n            {\n              \"source_id\": \"8\",\n              \"notes\": \"Describes CD38 function in NAD+ consuming reactions\"\n            },\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses CD38 upregulation in reactive glial cells\"\n            }\n          ],\n          \"genes\": [\n            \"CD38\"\n          ]\n        },\n        {\n          \"name\": \"Pattern recognition receptor signaling through TLR4\",\n          \"citations\": [\n            {\n              \"source_id\": \"7\",\n              \"notes\": \"Describes TLR4 signaling in immune responses\"\n            },\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses TLR4 roles in astrocyte reactivity\"\n            }\n          ],\n          \"genes\": [\n            \"TLR4\"\n          ]\n        },\n        {\n          \"name\": \"Inhibitor of differentiation protein-mediated proliferation\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses ID3 and ID4 in reactive astrocytes\"\n            },\n            {\n              \"source_id\": \"28\",\n              \"notes\": \"Details ID proteins in glioma stem cells\"\n            }\n          ],\n          \"genes\": [\n            \"ID3\",\n            \"ID4\"\n          ]\n        },\n        {\n          \"name\": \"YAP1-mediated transcriptional control of inflammatory responses\",\n          \"citations\": [\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"Discusses YAP1 in reactive astrocyte regulation\"\n            },\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Details YAP1 in neuroprotective versus neurotoxic astrocyte states\"\n            }\n          ],\n          \"genes\": [\n            \"YAP1\"\n          ]\n        },\n        {\n          \"name\": \"RFX4-mediated transcriptional regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses transcriptional regulators in astrocyte states\"\n            }\n          ],\n          \"genes\": [\n            \"RFX4\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Transition from resting to activated morphological state with process retraction\",\n        \"Upregulation of pro-inflammatory cytokine and chemokine expression\",\n        \"Enhanced immune cell recruitment through CD44 hyaluronic acid interactions\",\n        \"Altered energy metabolism through CD38-mediated NAD+ depletion\",\n        \"Loss of neuronal support functions in favor of inflammatory responses\",\n        \"Persistence of reactive phenotype in chronic disease states and astrocytoma\",\n        \"Potential dual role in both anti-tumor immunity and tumor-promoting inflammation\"\n      ],\n      \"evidence_summary\": \"The reactive astrocyte program involves coordinated upregulation of CD44, CD38, and TLR4 alongside changes in transcriptional control through ID proteins and YAP1. Recent evidence from traumatic brain injury studies reveals that astrocyte reactivity persists for extended periods following injury, with distinct transcriptional signatures associated with different stages of the reactive response. CD44 upregulation facilitates immune cell recruitment, while CD38 NAD+ consumption alters metabolic state. ID3 and ID4 promote continued proliferation characteristic of reactive astrocytes. YAP1 simultaneously drives pro-inflammatory gene expression while supporting metabolic adaptation. In astrocytoma, the reactive astrocyte phenotype likely promotes tumor progression through reduced anti-tumor immune function and metabolic support of tumor cells, while the heterogeneity of reactive states within the tumor microenvironment may create distinct functional domains supporting different aspects of tumor biology.\",\n      \"significance_score\": 0.87,\n      \"citations\": [\n        {\n          \"source_id\": \"14\",\n          \"notes\": \"Comprehensive analysis of astrocyte reactivity markers and APOE effects\"\n        },\n        {\n          \"source_id\": \"21\",\n          \"notes\": \"Details persistent astrocyte activation after TBI\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"CD44\",\n        \"CD38\",\n        \"TLR4\",\n        \"ID3\",\n        \"ID4\",\n        \"YAP1\",\n        \"RFX4\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"GFAP (astrocyte marker, downstream in reactive state)\",\n          \"IL-6, TNF-α, IL-1β (pro-inflammatory cytokines)\",\n          \"MCP-1/CCL2 (chemokine)\",\n          \"iNOS (inducible nitric oxide synthase)\",\n          \"MyD88 (TLR4 adaptor)\",\n          \"STAT3, NF-κB (downstream of TLR4)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"21\",\n            \"notes\": \"Discusses GFAP as marker and downstream inflammatory gene expression\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Calcium Signaling and Metabolic Adaptation\",\n      \"description\": \"Intracellular calcium serves as a critical second messenger regulating astrocyte metabolic state, gene expression, and synaptic interactions through multiple interconnected calcium-handling systems. ITPR2 gates inositol 1,4,5-trisphosphate-mediated calcium release from ER stores in response to phospholipase C activation downstream of growth factor and neurotransmitter receptors. CACNA2D3 encodes an auxiliary subunit of L-type calcium channels regulating calcium influx. Downstream calcium-responsive effectors including calcineurin and calmodulin-dependent kinases integrate calcium signals with metabolic and transcriptional responses. Recent evidence reveals bidirectional calcium-mitochondrial interactions, with excessive ITPR2-mediated calcium transfer to mitochondria promoting mitochondrial dysfunction and contributing to senescence and neuroinflammation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"IP3-mediated ER calcium release\",\n          \"citations\": [\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"Details ITPR2 function in ammonia-induced metabolic changes\"\n            },\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Comprehensive discussion of ITPR2 in calcium handling and senescence\"\n            },\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses IP3 signaling in astrocyte calcium dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        },\n        {\n          \"name\": \"Voltage-gated calcium channel regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Discusses calcium channels in astrocyte excitability\"\n            }\n          ],\n          \"genes\": [\n            \"CACNA2D3\"\n          ]\n        },\n        {\n          \"name\": \"Calcineurin-NFAT signaling and calcium-dependent gene expression\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Details calcineurin-NFAT pathway in astrocyte reactivity and neurovascular coupling\"\n            }\n          ],\n          \"genes\": []\n        },\n        {\n          \"name\": \"Mitochondrial calcium uptake and oxidative phosphorylation coupling\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Details mitochondrial calcium uniporter function and ROS production\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Comprehensive review of mitochondrial calcium in senescence\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        },\n        {\n          \"name\": \"Mitochondrial permeability transition and apoptosis\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Discusses mPTP calcium-dependent opening\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Details mPTP flickering in senescent cells\"\n            }\n          ],\n          \"genes\": []\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"IP3 receptor calcium-release channel\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Describes ITPR structure and function\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        },\n        {\n          \"name\": \"Voltage-gated L-type calcium channels\",\n          \"citations\": [\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"Discusses calcium channel subunits\"\n            }\n          ],\n          \"genes\": [\n            \"CACNA2D3\"\n          ]\n        },\n        {\n          \"name\": \"ER-mitochondria contact sites (MERCS)\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Describes MERCS structure and calcium transfer\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Details MERCS in senescence\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Coupling of neuronal activity sensing to metabolic adaptation\",\n        \"Astrocyte lactate production in response to elevated calcium/glutamate uptake\",\n        \"Calcium-dependent transcriptional control of pro-inflammatory genes\",\n        \"Mitochondrial calcium overload promoting ROS production and senescence\",\n        \"Dysregulated calcium signaling in reactive astrocytes contributing to chronic neuroinflammation\",\n        \"Altered calcium dynamics in astrocytoma supporting metabolic flexibility and tumor cell survival\"\n      ],\n      \"evidence_summary\": \"ITPR2 represents a central calcium-handling component linking growth factor signaling to intracellular calcium dynamics and mitochondrial metabolism. Excessive ITPR2-mediated calcium transfer to mitochondria through ER-mitochondrial contact sites (MERCS) causes mitochondrial calcium accumulation, reduces mitochondrial membrane potential, and elevates ROS production, creating a positive feedback loop promoting senescence and chronic neuroinflammatory states. CACNA2D3 provides auxiliary regulation of L-type calcium channel function. In reactive astrocytes and astrocytoma-associated astrocytes, dysregulated calcium signaling may simultaneously promote pro-inflammatory gene expression while disrupting optimal metabolic function, contributing to both anti-tumor and pro-tumor effects depending on specific context. Evidence that ITPR2 knockdown prevents senescence induction suggests therapeutic potential for modulating this program.\",\n      \"significance_score\": 0.83,\n      \"citations\": [\n        {\n          \"source_id\": \"35\",\n          \"notes\": \"Comprehensive review of mitochondrial dysfunction and ITPR2 calcium signaling\"\n        },\n        {\n          \"source_id\": \"40\",\n          \"notes\": \"Discusses astrocyte calcium signaling in neurovascular coupling\"\n        },\n        {\n          \"source_id\": \"64\",\n          \"notes\": \"Reviews calcium handling in cellular senescence\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"ITPR2\",\n        \"CACNA2D3\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"PLCB (phospholipase C beta, IP3 generation)\",\n          \"MCU (mitochondrial calcium uniporter)\",\n          \"NCLX (mitochondrial sodium-calcium exchanger)\",\n          \"Calcineurin (calcium-dependent phosphatase)\",\n          \"CaMKII (calcium-calmodulin kinase)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"40\",\n            \"notes\": \"Lists calcium-dependent effectors\"\n          },\n          {\n            \"source_id\": \"35\",\n            \"notes\": \"Discusses mitochondrial calcium transporters\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Transcriptional Control of Differentiation and Stem Cell Maintenance\",\n      \"description\": \"The genes ID3, ID4, YAP1, RFX4, and ZNF521 collectively regulate transcriptional programs governing cell proliferation, differentiation state, and maintenance of stem/progenitor cell characteristics. ID proteins function as dominant-negative inhibitors of basic helix-loop-helix transcription factors critical for differentiation; their upregulation maintains proliferative potential while antagonizing terminal differentiation. YAP1 acts as a master regulator of stem cell properties and metabolic flexibility through interaction with TEAD transcription factors and modulation of HIPPO pathway signaling. RFX4 plays roles in neuronal and glial lineage specification. ZNF521 supports stem cell maintenance. This program directly enables the cellular plasticity characteristic of astrocytoma, wherein tumor cells maintain progenitor-like transcriptional states despite expressing some differentiation markers.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"bHLH transcription factor antagonism by ID proteins\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses ID protein function in reactive astrocytes\"\n            },\n            {\n              \"source_id\": \"28\",\n              \"notes\": \"Details ID proteins in glioma stem cell maintenance\"\n            }\n          ],\n          \"genes\": [\n            \"ID3\",\n            \"ID4\"\n          ]\n        },\n        {\n          \"name\": \"YAP1-TEAD transcriptional regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"Discusses YAP1-TEAD complex in astrocyte gene regulation\"\n            },\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Details YAP1 transcriptional targets and neuroprotective effects\"\n            }\n          ],\n          \"genes\": [\n            \"YAP1\"\n          ]\n        },\n        {\n          \"name\": \"Hippo pathway signaling and YAP1 activation\",\n          \"citations\": [\n            {\n              \"source_id\": \"22\",\n              \"notes\": \"Details Hippo-YAP pathway regulation of glutamine synthetase\"\n            },\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Comprehensive discussion of Hippo-YAP signaling in development and disease\"\n            }\n          ],\n          \"genes\": [\n            \"YAP1\"\n          ]\n        },\n        {\n          \"name\": \"RFX4-mediated transcriptional regulation of neuronal/glial programs\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Mentions RFX4 in transcriptional control\"\n            }\n          ],\n          \"genes\": [\n            \"RFX4\"\n          ]\n        },\n        {\n          \"name\": \"ZNF521-mediated stem cell maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses ZNF521 in stem cell regulation\"\n            }\n          ],\n          \"genes\": [\n            \"ZNF521\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Maintenance of proliferative potential in progenitor-like astrocytes\",\n        \"Antagonism of terminal differentiation through ID protein-mediated bHLH inhibition\",\n        \"YAP1-driven metabolic reprogramming supporting stemness\",\n        \"Preservation of plasticity enabling lineage transitions in response to microenvironmental signals\",\n        \"Enhanced tumor cell survival and self-renewal in astrocytoma through sustained stemness\",\n        \"Resistance to differentiation-based therapies through ID and YAP1 overexpression\"\n      ],\n      \"evidence_summary\": \"Recent glioblastoma studies reveal that tumor progression involves activation of an INSM1-driven intermediate progenitor state, with maintained plasticity enabling transitions between different molecular subtypes. ID proteins antagonize bHLH differentiation factors, maintaining proliferative capacity while reducing differentiation pressure. YAP1 functions as a master regulator of stemness through TEAD interaction, simultaneously promoting metabolic flexibility and survival signaling. The presence of multiple stemness-regulating transcription factors (ID3, ID4, YAP1, RFX4, ZNF521) in the input list suggests that astrocytoma cells maintain access to developmental transcriptional programs normally restricting stemness, enabling the cellular plasticity observed in these tumors. Evidence that YAP1 can simultaneously support neuroprotective functions while driving stemness and metabolic flexibility suggests context-dependent program regulation in tumor versus normal tissue.\",\n      \"significance_score\": 0.86,\n      \"citations\": [\n        {\n          \"source_id\": \"28\",\n          \"notes\": \"Details INSM1-driven progenitor state in glioblastoma\"\n        },\n        {\n          \"source_id\": \"24\",\n          \"notes\": \"Comprehensive discussion of YAP1 in development and disease\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"ID3\",\n        \"ID4\",\n        \"YAP1\",\n        \"RFX4\",\n        \"ZNF521\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"TEAD1-4 (TEA domain transcription factors, YAP1 partners)\",\n          \"SOX2 (master stem cell regulator)\",\n          \"NOTCH1 (developmental signaling)\",\n          \"WNT pathway components (β-catenin, TCF/LEF)\",\n          \"INSM1 (intermediate progenitor state driver in glioma)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"28\",\n            \"notes\": \"Discusses SOX2 and INSM1 in glioma stem cell biology\"\n          },\n          {\n            \"source_id\": \"24\",\n            \"notes\": \"Mentions TEAD as YAP1 partner\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Mitochondrial Quality Control and Senescence Prevention\",\n      \"description\": \"Astrocytes maintain mitochondrial health through quality control mechanisms including selective autophagy (mitophagy) and degradation of damaged organelles. FKBP5, encoding an immunophilin involved in protein folding and stress responses, contributes to cellular stress adaptation. YAP1, while discussed primarily in other contexts, also prevents premature senescence of astrocytes through regulation of CDK6 signaling and metabolic adaptation. Dysregulation of this program occurs through impaired mitophagy, accumulation of dysfunctional mitochondria with elevated ROS production, and persistent DNA damage responses characteristic of cellular senescence. Senescent astrocytes produce pro-inflammatory SASP factors that paradoxically may either oppose or support tumor progression depending on context.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Mitochondrial selective autophagy (mitophagy)\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Comprehensive discussion of PINK1/Parkin-mediated mitophagy\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Details S-nitrosylation of Parkin and mitophagy impairment in senescence\"\n            }\n          ],\n          \"genes\": []\n        },\n        {\n          \"name\": \"FKBP5-mediated protein folding and stress response\",\n          \"citations\": [\n            {\n              \"source_id\": \"15\",\n              \"notes\": \"Details FKBP5 in HPA axis signaling and stress responses\"\n            }\n          ],\n          \"genes\": [\n            \"FKBP5\"\n          ]\n        },\n        {\n          \"name\": \"YAP1-mediated senescence prevention\",\n          \"citations\": [\n            {\n              \"source_id\": \"24\",\n              \"notes\": \"Describes YAP1 prevention of astrocyte senescence through CDK6\"\n            }\n          ],\n          \"genes\": [\n            \"YAP1\"\n          ]\n        },\n        {\n          \"name\": \"ROS-mediated DNA damage and persistent DDR\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Details ROS generation and ATM-AKT-mTORC1 signaling cascade\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Comprehensive discussion of oxidative stress and senescence\"\n            }\n          ],\n          \"genes\": []\n        },\n        {\n          \"name\": \"Senescence-associated secretory phenotype (SASP) production\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Details SASP factors and their production mechanisms\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Discusses inflammatory cytokine production by senescent cells\"\n            }\n          ],\n          \"genes\": []\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Dysfunctional mitochondria accumulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"Describes mitochondrial morphological changes and quality loss\"\n            },\n            {\n              \"source_id\": \"64\",\n              \"notes\": \"Details increased mitochondrial mass in senescent cells\"\n            }\n          ],\n          \"genes\": []\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Maintenance of healthy mitochondrial population through selective autophagy\",\n        \"Prevention of ROS accumulation and oxidative damage\",\n        \"Reduced persistent DNA damage responses and senescence\",\n        \"Preserved astrocyte metabolic flexibility and support functions\",\n        \"Reduced SASP-mediated chronic neuroinflammation\",\n        \"Accumulation of senescent astrocytes in aging brain and chronic disease states contributing to neuroinflammation\",\n        \"Complex effects of SASP factors in astrocytoma potentially both limiting and promoting tumor progression\"\n      ],\n      \"evidence_summary\": \"Mitochondrial quality control represents a critical determinant of astrocyte health, with impaired mitophagy leading to accumulation of dysfunctional organelles, ROS accumulation, and senescence induction. FKBP5 contributes to cellular stress responses and protein folding capacity in response to physiological stress including HPA axis activation. YAP1 actively prevents senescence through CDK6 signaling and metabolic adaptation. In aging brain and chronic neurodegenerative disease, accumulated senescent astrocytes display impaired mitochondrial quality control, producing pro-inflammatory SASP factors that chronically activate local immune cells. In astrocytoma, senescent cell-derived SASP may create a pro-inflammatory microenvironment potentially supporting immune suppression and tumor progression, while in other contexts may limit tumor development. The importance of this program is underscored by recent findings that therapeutic targeting of senescent cells (senolytics) improves age-related cognitive decline.\",\n      \"significance_score\": 0.72,\n      \"citations\": [\n        {\n          \"source_id\": \"35\",\n          \"notes\": \"Comprehensive review of mitochondrial dysfunction in senescence\"\n        },\n        {\n          \"source_id\": \"64\",\n          \"notes\": \"Detailed discussion of mitochondrial quality control and senescence\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"YAP1\",\n        \"FKBP5\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"PINK1 (mitophagy receptor)\",\n          \"Parkin (E3 ubiquitin ligase for mitophagy)\",\n          \"p62 (autophagy adaptor)\",\n          \"ATM (DNA damage sensor)\",\n          \"p53 (senescence inducer)\",\n          \"p16, p21 (CDK inhibitors in senescence)\",\n          \"mTORC1 (nutrient and energy sensor)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"35\",\n            \"notes\": \"Lists mitophagy and senescence pathway components\"\n          },\n          {\n            \"source_id\": \"64\",\n            \"notes\": \"Comprehensive pathway listing for mitochondrial dysfunction and senescence\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Growth Factor Signaling and Metabolic Adaptation\",\n      \"description\": \"Astrocytes respond to multiple growth factor signaling cascades that drive proliferation, survival, and metabolic adaptation. NTRK2 (TrkB) responds to brain-derived neurotrophic factor (BDNF) activation, engaging PI3K-AKT and MAPK signaling cascades. NRG3 (neuregulin-3) signals through ErbB receptor family members including ERBB4. ADCY2 and ADCY8 encode adenylyl cyclases generating cAMP second messengers downstream of Gαs-coupled receptors. ADRA1A encodes alpha-1A adrenergic receptor signaling to phospholipase C and calcium mobilization. PRKG1 encodes protein kinase G activated by cGMP in response to nitric oxide signaling. These pathways collectively integrate growth factor, neurotransmitter, and vasoactive signals to coordinate astrocyte metabolic state with microenvironmental demands.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"BDNF-TrkB-PI3K-AKT signaling for survival\",\n          \"citations\": [\n            {\n              \"source_id\": \"21\",\n              \"notes\": \"Details NTRK2 downregulation acutely after TBI but upregulation in chronic phase\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Describes TRIM24::NTRK2 fusion-driven signaling in astrocytoma\"\n            }\n          ],\n          \"genes\": [\n            \"NTRK2\"\n          ]\n        },\n        {\n          \"name\": \"BDNF-TrkB-MAPK signaling for proliferation\",\n          \"citations\": [\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Details pERK activation through NTRK2 signaling\"\n            }\n          ],\n          \"genes\": [\n            \"NTRK2\"\n          ]\n        },\n        {\n          \"name\": \"Neuregulin-ErbB signaling in astrocyte development\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Describes NRG1 and ErbB signaling in nervous system development\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Discusses NRG3 in astrocyte signaling\"\n            }\n          ],\n          \"genes\": [\n            \"NRG3\",\n            \"ERBB4\"\n          ]\n        },\n        {\n          \"name\": \"Adenylyl cyclase-cAMP signaling downstream of Gαs receptors\",\n          \"citations\": [\n            {\n              \"source_id\": \"14\",\n              \"notes\": \"Discusses cAMP signaling in astrocyte responses\"\n            }\n          ],\n          \"genes\": [\n            \"ADCY2\",\n            \"ADCY8\"\n          ]\n        },\n        {\n          \"name\": \"α1-adrenergic receptor signaling to PLC and calcium mobilization\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Discusses noradrenergic signaling in astrocyte responses\"\n            }\n          ],\n          \"genes\": [\n            \"ADRA1A\"\n          ]\n        },\n        {\n          \"name\": \"Nitric oxide-cGMP-PKG signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"40\",\n              \"notes\": \"Details nitric oxide and cGMP signaling in neurovascular coupling\"\n            }\n          ],\n          \"genes\": [\n            \"PRKG1\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [],\n      \"predicted_cellular_impact\": [\n        \"Astrocyte survival and proliferation in response to BDNF-TrkB signaling\",\n        \"NTRK2 fusion-driven constitutive activation in subset of pediatric astrocytomas\",\n        \"Metabolic adaptation to growth signals through MAPK and PI3K pathway activation\",\n        \"cAMP-mediated responses to catecholamine and other Gαs signals\",\n        \"Integration of multiple growth factor inputs enabling flexible metabolic responses\",\n        \"Enhanced tumor cell growth through NTRK2 fusion-mediated signaling in specific molecular subtypes\",\n        \"Vulnerability to targeted kinase inhibitors in NTRK-driven astrocytomas\"\n      ],\n      \"evidence_summary\": \"NTRK2 represents a critical survival and proliferation signal for astrocytes under normal conditions, but becomes pathogenic when constitutively activated through fusion events in certain pediatric astrocytomas. Recent evidence demonstrates that TRIM24::NTRK2 fusion proteins drive oncogenic signaling through both PI3K-AKT and MAPK-ERK pathways, with particularly strong activation of S6 kinase suggesting mTORC1 engagement. NRG3-ERBB4 signaling provides complementary developmental signals. Multiple adenylyl cyclase isoforms (ADCY2, ADCY8) generate cAMP in response to diverse upstream signals including β-adrenergic receptors and other Gαs-coupled receptors, enabling broad metabolic adaptation. ADRA1A signaling through alpha-1A receptors mobilizes calcium and activates phospholipase C. PRKG1 integration of nitric oxide signaling connects astrocyte function to vascular signals. In astrocytoma, dysregulation of this program through NTRK fusion proteins drives constitutive proliferation signals, while enhanced sensitivity to metabolic stress from adenylyl cyclase signaling dysregulation may create therapeutic vulnerabilities.\",\n      \"significance_score\": 0.84,\n      \"citations\": [\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"Comprehensive analysis of NTRK2 fusion in astrocytoma\"\n        },\n        {\n          \"source_id\": \"21\",\n          \"notes\": \"Details NTRK2 roles in astrocyte response to injury\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"NTRK2\",\n        \"NRG3\",\n        \"ERBB4\",\n        \"ADCY2\",\n        \"ADCY8\",\n        \"ADRA1A\",\n        \"PRKG1\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"BDNF (NTRK2 ligand)\",\n          \"NRG1 (ErbB ligand)\",\n          \"PI3K, AKT (NTRK2 downstream effectors)\",\n          \"MAPK/ERK cascade (NTRK2 downstream)\",\n          \"mTORC1 (downstream of AKT)\",\n          \"β-adrenergic receptors (ADCY activators)\",\n          \"Gαs/Golf (ADCY activators)\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"26\",\n            \"notes\": \"Lists signaling pathways downstream of NTRK2\"\n          }\n        ]\n      }\n    }\n  ],\n  \"method\": {\n    \"clustering_basis\": [\n      \"Functional annotation and pathway database analysis\",\n      \"Co-expression in astrocytes across multiple studies\",\n      \"Shared cellular localization and protein complex membership\",\n      \"Disease association in astrocytoma molecular subtypes\",\n      \"Mechanistic literature linking genes to common biological processes\",\n      \"Integration of single-cell transcriptomic and spatial transcriptomic data from glioma studies\"\n    ],\n    \"notes\": \"Gene programs identified through systematic review of functional literature on individual genes, followed by clustering based on shared biological processes, cellular compartments, and pathway membership. Special emphasis on genes dysregulated in astrocytoma versus normal astrocytes and on programs critical for both normal astrocyte physiology and tumor-associated alterations. Programs validated through reference to recent single-cell and spatial transcriptomic studies of astrocytes in health and disease.\"\n  },\n  \"version\": \"1.0\"\n}\n```",
    "citations": [
      "https://www.ncbi.nlm.nih.gov/gene/2670",
      "https://www.nature.com/articles/s41588-025-02419-4",
      "https://www.nature.com/articles/s41598-025-27335-9",
      "https://www.ncbi.nlm.nih.gov/gene/23627",
      "https://www.nature.com/articles/s41698-025-01155-6",
      "https://www.nature.com/articles/s42003-025-09270-7",
      "https://www.ncbi.nlm.nih.gov/gene/21898",
      "https://www.ncbi.nlm.nih.gov/gene/12494",
      "https://www.nature.com/articles/s41593-025-02123-w",
      "https://www.ncbi.nlm.nih.gov/gene/6507",
      "https://www.ncbi.nlm.nih.gov/gene/20655",
      "https://www.ncbi.nlm.nih.gov/gene/20512",
      "https://www.ncbi.nlm.nih.gov/gene/211323",
      "https://www.nature.com/articles/s43856-025-01171-4",
      "https://www.nature.com/articles/s41531-025-01167-w",
      "https://www.nature.com/articles/s41514-025-00295-0",
      "https://www.ncbi.nlm.nih.gov/gene/11835",
      "https://www.nature.com/articles/s41514-025-00291-4",
      "https://www.nature.com/articles/s42003-025-08959-z",
      "https://www.ncbi.nlm.nih.gov/gene/18018",
      "https://www.nature.com/articles/s42003-025-09138-w",
      "https://www.nature.com/articles/s42003-025-09191-5",
      "https://www.nature.com/articles/s41467-025-66871-w_reference.pdf",
      "https://pubmed.ncbi.nlm.nih.gov/41390137/?fc=None&ff=20251214151330&v=2.18.0.post22+67771e2",
      "https://www.ncbi.nlm.nih.gov/gene/4323",
      "https://www.nature.com/articles/s41698-025-01190-3",
      "https://www.ncbi.nlm.nih.gov/gene/4613",
      "https://www.nature.com/articles/s41467-025-66371-x",
      "https://pubmed.ncbi.nlm.nih.gov/41292395/",
      "https://www.ncbi.nlm.nih.gov/gene/29126",
      "https://www.ncbi.nlm.nih.gov/gene/546",
      "https://www.nature.com/articles/s42003-025-09122-4",
      "https://www.ncbi.nlm.nih.gov/gene/4137",
      "https://www.ncbi.nlm.nih.gov/gene/5594",
      "https://www.ncbi.nlm.nih.gov/gene/8678",
      "https://www.ncbi.nlm.nih.gov/gene/5894",
      "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "https://www.nature.com/articles/s41467-025-66521-1",
      "https://www.nature.com/articles/s44324-025-00090-1",
      "https://www.ncbi.nlm.nih.gov/gene/998",
      "https://www.nature.com/articles/s41467-025-67166-w_reference.pdf",
      "https://www.ncbi.nlm.nih.gov/gene/3399",
      "https://www.ncbi.nlm.nih.gov/gene/19016",
      "https://www.nature.com/articles/s41467-025-66985-1",
      "https://www.ncbi.nlm.nih.gov/gene/57591",
      "https://www.ncbi.nlm.nih.gov/gene/19013",
      "https://www.ncbi.nlm.nih.gov/gene/207",
      "https://www.ncbi.nlm.nih.gov/gene/4790",
      "https://www.nature.com/articles/s41421-025-00842-9",
      "https://www.ncbi.nlm.nih.gov/gene/1385",
      "https://www.ncbi.nlm.nih.gov/gene/7076",
      "https://www.ncbi.nlm.nih.gov/gene/10763",
      "https://www.nature.com/articles/s42003-025-08988-8",
      "https://www.nature.com/articles/s41467-025-65095-2",
      "https://www.nature.com/articles/s41467-025-66543-9",
      "https://www.ncbi.nlm.nih.gov/gene/13649",
      "https://www.ncbi.nlm.nih.gov/gene/2697",
      "https://pubmed.ncbi.nlm.nih.gov/41332782/",
      "https://www.ncbi.nlm.nih.gov/gene/56717",
      "https://www.science.org/doi/10.1126/sciadv.adz9283",
      "https://www.nature.com/articles/s41593-025-02100-3",
      "http://json-schema.org/draft-07/schema#\","
    ],
    "duration_seconds": 292.078232049942
  }
}